Year 2021 Vol. 29 No 5




Institute of Physiology NAS of Belarus, Minsk,
The Republic of Belarus

Objective. To estimate an anti-nociceptive and regenerative potential of adipose-derived mesenchymal stem cells in experimental post-traumatic neuropathy in rats.
Methods. Neuropathic pain was induced by axotomy technique in rat left hind paw (Wistar rats (n=113)). The respective group of subjects received ADMSCs dose of 1×106 cells/kg and 2×106 cells/kg into the site of sciatic nerve injury at 2 regimens: single (7th day post-surgery) and twice (7th and 14th day post-surgery). Nociceptive responses, as well as histological changes of sciatic nerve and perineural tissue were assessed in dynamics.
Results. Sciatic nerve axotomy led to a significant increase of mechanical nociceptive sensitivity of ipsilateral hind paw by 7th day, as well as to fibrotic changes of peri- and epineural areas of damaged nerve fibers and to denervation of surrounding muscle tissue and fascia. Local administration of ADMSCs effectively abolished mechanical hyperalgesia by 14th day after first injection at all regimens tested. Among tested regimens, the most pronounced anti-nociceptive and regenerative effects were induced by single injection of ADMSCs (1×106 cells/kg). As the dose and frequency of ADMSCs administration elevated, their reparative and anti-inflammatory properties reduced.
Conclusion. Obtained results testify anti-nociceptive potential of ADMSCs and feasibility of its further investigation on the experimental models of neuropathy.

Keywords: mesenchymal stem cells, adipose tissue, neuropathy, pain, sciatic nerve, hyperalgesia
p. 527-534 of the original issue
  1. Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev Neurol (Paris). 2019 Jan-Feb;175(1-2):16-25. doi: 10.1016/j.neurol.2018.09.016
  2. Bannister K, Sachau J, Baron R, Dickenson AH. Neuropathic Pain: Mechanism-Based Therapeutics. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:257-74. doi: 10.1146/annurev-pharmtox-010818-021524
  3. Alles SRA, Smith PA. Etiology and Pharmacology of Neuropathic Pain. Pharmacol Rev. 2018 Apr;70(2):315-47. doi: 10.1124/pr.117.014399
  4. Smith BH, Hébert HL, Veluchamy A. Neuropathic pain in the community: prevalence, impact, and risk factors. Pain. 2020 Sep;161 Suppl 1:S127-S137. doi: 10.1097/j.pain.0000000000001824
  5. Murnion BP. Neuropathic pain: current definition and review of drug treatment. Aust Prescr. 2018 Jun;41(3):60-63. doi: 10.18773/austprescr.2018.022
  6. Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007076. doi: 10.1002/14651858.CD007076.pub3
  7. Yekkirala AS, Roberson DP, Bean BP, Woolf CJ. Breaking barriers to novel analgesic drug development. Nat Rev Drug Discov. 2017 Aug;16(8):545-64. doi: 10.1038/nrd.2017.87
  8. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019 Aug 13;8(8):886. doi: 10.3390/cells8080886
  9. Zhou Y, Yamamoto Y, Xiao Z, Ochiya T. The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity. J Clin Med. 2019 Jul 12;8(7):1025. doi: 10.3390/jcm8071025
  10. Park KS, Bandeira E, Shelke GV, Lässer C, Lötvall J. Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2019 Sep 23;10(1):288. doi: 10.1186/s13287-019-1398-3
  11. Deuis JR, Dvorakova LS, Vetter I. Methods Used to Evaluate Pain Behaviors in Rodents. Front Mol Neurosci. 2017 Sep 6;10:284. doi: 10.3389/fnmol.2017.00284. eCollection 2017.
  12. Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019 May 16;8(5):467. doi: 10.3390/cells8050467
Address for correspondence:
220072, Republic of Belarus,
Minsk, Akademicheskaya Str., 28,
Institute of Physiology NAS of Belarus,
the Laboratory for Modulation of Body Functions,
Yerofeyeva Anna-Maria V.
Information about the authors:
Yerofeyeva Anna-Maria V., Post-Graduate Student, Junior Researcher of the Laboratory for Modulation of Body Functions, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.
Zhavaranak Irina P., PhD, Senior Researcher of the Laboratory for Modulation of Body Functions, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.
Antipova Olga A., Researcher of the Laboratory for Modulation of Body Functions, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.
Schastnaya Nadezhda I., Researcher of the Laboratory for Modulation of Body Functions, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.
Siamionik Irina A., PhD, Senior Researcher of the Center for Light and Electron Microscopy, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.
Rjabceva Svetlana N., PhD, Head of the Laboratory, Leading Researcher of the Center for Light and Electron Microscopy, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.
Molchanova Alla Yu., PhD, Head of the Laboratory, Leading Researcher, the Laboratory for Modulation of Body Functions, Institute of Physiology NAS of Belarus, Minsk, Republic of Belarus.




Cologne University Clinic 1, Cologne,
I.P. Pavlov Ryazan State Medical University 2, Ryazan,
Russian Federation,
Republican Scientific Center for Cardiovascular Surgery of the Ministry of Health and Social Protection of the Population 3, Dushanbe,
Avicenna Tajik State Medical University 4, Dushanbe,
Republic of Tajikistan

Objective. To compare the demographics, comorbidities and risk factors in patients with abdominal aortic aneurysm (AAA) treated in three different communities; Germany, Tajikistan and Russian Federation.
Methods. A retrospective comparative study including patients with an infrarenal AAA who were treated with either endovascular aneurysm repair (EVAR) or open repair (2011-2015) in Cologne, Dushanbe and Ryazan was done. A total number of 711 patients, 499 from Cologne, 46 from Dushanbe and 166 from Ryazan were included in the study. Demographic data including age, gender, body mass index (BMI), comorbidities (diabetes, coronary artery disease (CAD)), hypertension, cerebrovascular disease, chronic obstructive pulmonary disease (COPD, smoking), actual treatment as well as the diameter of the abdominal aorta were collected, retrospectively.
Results. There was no statistically significant difference in AAA prevalence with respect to gender between the study centers. Similarly, the BMI did not differ significantly between these 3 centers. Though, the patients from Cologne were older than those from Dushanbe and Ryazan. Moreover, the number of patients treated due to ruptured aneurysm was significantly lower in Cologne in comparison to the other two centers (P<.05). The AAA-diameter of patients in Ryazan and Dushanbe was greater than that found in Cologne. Regarding the actual medication that patients were presented with, antiplatelet-aggregation medication, statin and beta blockers were used significantly more often in Cologne. Patients from Tajikistan had COPD more often than patients from the other centers.
Conclusion. The prevalence of comorbidities, risk factors as well as medication in patients with infrarenal abdominal aortic aneurysm is different in the various geographical regions.

Keywords: abdominal aortic aneurysm, ruptured aneurysm, risk factors, demographic differences, mortality, endovascular treatment
p. 535-541 of the original issue
  1. Gawenda M, Brunkwall J. Ruptured abdominal aortic aneurysm: the state of play. Dtsch Arztebl Int. 2012 Oct;109(43):727-32. doi: 10.3238/arztebl.2012.0727
  2. Hoornweg LL, Storm-Versloot MN, Ubbink DT, Koelemay MJ, Legemate DA, Balm R. Meta analysis on mortality of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2008 May;35(5):558-70. doi: 10.1016/j.ejvs.2007.11.019
  3. Vänni V, Turtiainen J, Hakala T, Salenius J, Suominen V, Oksala N, Hernesniemi J. Vascular comorbidities and demographics of patients with ruptured abdominal aortic aneurysms. Surgery. 2016 Apr;159(4):1191-98. doi: 10.1016/j.surg.2015.10.005
  4. Sakalihasan N, Michel JB, Katsargyris A, Kuivaniemi H, Defraigne JO, Nchimi A, Powell JT, Yoshimura K, Hultgren R. Abdominal aortic aneurysms. Nat Rev Dis Primers. 2018 Oct 18;4(1):34. doi: 10.1038/s41572-018-0030-7. Review.
  5. Xiong J, Wu Z, Chen C, Guo W. Chronic obstructive pulmonary disease effect on the prevalence and postoperative outcome of abdominal aortic aneurysms: A meta-analysis. Sci Rep. 2016 Apr 26;6:25003. doi: 10.1038/srep25003
  6. Wanhainen A, Verzini F, Van Herzeele I, Allaire E, Bown M, Cohnert T, Dick F, van Herwaarden J, Karkos C, Koelemay M, Kölbel T, Loftus I, Mani K, Melissano G, Powell J, Szeberin Z, Esvs Guidelines Committee, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Kolh P, Lindholt JS, de Vega M, Vermassen F, Document Reviewers, Björck M, Cheng S, Dalman R, Davidovic L, Donas K, Earnshaw J, Eckstein HH, Golledge J, Haulon S, Mastracci T, Naylor R, Ricco JB, Verhagen H. Editors Choice European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93. doi: 10.1016/j.ejvs.2018.09.020
  7. Budtz-Lilly J, Venermo M, Debus S, Behrendt CA, Altreuther M, Beiles B, Szeberin Z, Eldrup N, Danielsson G, Thomson I, Wigger P, Björck M, Loftus I, Mani K. Editors Choice - Assessment of International Outcomes of Intact Abdominal Aortic Aneurysm Repair over 9 Years. Eur J Vasc Endovasc Surg. 2017 Jul;54(1):13-20. doi: 10.1016/j.ejvs.2017.03.003
  8. Tang W, Yao L, Roetker NS, Alonso A, Lutsey PL, Steenson CC, Lederle FA, Hunter DW, Bengtson LG, Guan W, Missov E, Folsom AR. Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities). Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2468-77. doi: 10.1161/ATVBAHA.116.308147
  9. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010 Sep;52(3):539-48. doi: 10.1016/j.jvs.2010.05.090
  10. Wang SW, Huang YB, Huang JW, Chiu CC, Lai WT, Chen CY. Epidemiology, Clinical Features, and Prescribing Patterns of Aortic Aneurysm in Asian Population From 2005 to 2011. Medicine (Baltimore). 2015 Oct;94(41):e1716. doi: 10.1097/MD.0000000000001716
  11. Heidemann F, Meier U, Kölbel T, Atlihan G, Debus ES. How can an AAA screening program be implemented in Germany? Gefässchirurgie. 2015;20(Suppl 1):28-31. doi: 10.1007/s00772-014-1392-0
  12. Li X, Zhao G, Zhang J, Duan Z, Xin S. Prevalence and trends of the abdominal aortic aneurysms epidemic in general population a meta-analysis. PLoS One. 2013 Dec 2;8(12):e81260. doi: 10.1371/journal.pone.0081260. eCollection 2013
  13. Aune D, Schlesinger S, Norat T, Riboli E. Diabetes mellitus and the risk of abdominal aortic aneurysm: A systematic review and meta-analysis of prospective studies. J Diabetes Complications. 2018 Dec;32(12):1169-74. doi: 10.1016/j.jdiacomp.2018.09.009
  14. Kühnl A, Erk A, Trenner M, Salvermoser M, Schmid V, Eckstein HH. Incidence, treatment and mortality in patients with abdominal aortic aneurysms. Dtsch Arztebl Int. 2017 Jun 5;114(22-23):391-98. doi: 10.3238/arztebl.2017.0391
  15. Takagi H, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Coronary artery disease and abdominal aortic aneurysm growth. Vasc Med. 2016 Jun;21(3):199-208. doi: 10.1177/1358863X15624026
  16. Elkalioubie A, Haulon S, Duhamel A, Rosa M, Rauch A, Staels B, Susen S, Van Belle E, Dupont A. Meta-analysis of abdominal aortic aneurysm in patients with coronary artery disease. Am J Cardiol. 2015 Nov 1;116(9):1451-56. doi: 10.1016/j.amjcard.2015.07.074
  17. Stackelberg O, Björck M, Sadr-Azodi O, Larsson SC, Orsini N, Wolk A. Obesity and abdominal aortic aneurysm. Br J Surg. 2013 Feb;100(3):360-66. doi: 10.1002/bjs.8983
Address for correspondence:
Clinic of Vascular and Endovascular Surgery,
Helios University Clinic. Wuppertal, Germany, Heusener Street 40,
42283, Wuppertal,
Kalmykov Egan L.
Information about the authors:
Kalmykov Egan L., PhD, Vascular Surgeon, Clinic of Vascular and Endovascular Surgery, Helios University Clinic. Wuppertal, Germany.
Ahmad Wael, Doctor of Medicine, Department of Vascular and Endovascular Surgery, University Clinics, University of Cologne, Cologne, Germany.
Suchkov Igor A., MD, Professor, Vice-Rector for Research and Innovative Development, Professor of the Department of Cardiovascular, X-ray Endovascular, Operatives and Topographic Anatomy, I.P. Pavlov Ryazan State Medical University, Ryazan, Russian Federation
Kalinin Roman E., MD, Professor, Rector, Head of the Department of Cardiovascular, X-ray Endovascular, Operatives and Topographic Anatomy, I.P. Pavlov Ryazan State Medical University, Ryazan, Russian Federation

Nematzoda Okildzhon, PhD, Leading Researcher, Republican Scientific Center for Cardiovascular Surgery of the Ministry of Health and Social Protection of the Population, Dushanbe, Republic of Tajikistan.

Gaibov Alidzhon D., Corresponding Member of AMS of RT, MD, Professor of the Department of Surgical Diseases No2, Avicenna Tajik State Medical University, Republican Scientific Center for Cardiovascular Surgery of the Ministry of Health and Social Protection of the Population, Dushanbe, Republic of Tajikistan.
Sultanov Dzhavili D., MD, Professor of the Department of Surgical Diseases No2, Avicenna Tajik State Medical University Dushanbe, Republic of Tajikistan.
Majd Payman, Doctor of medicine, Clinic of Vascular and Endovascular Surgery, Cologne University Clinic, Cologne, Germany.
Brunkwall Jan, Professor, Clinic of Vascular and Endovascular Surgery, Cologne University Clinic, Cologne, Germany.



A.A. Bogomolets National Medical University, Kiev,

Objective. To study of the role of Helicobacter pylori as an etiological factor of acute pancreatitis and a marker of the development of its purulent-septic complications.
ethods. The study was conducted in the period of 2015-2020; patients with acute pancreatitis (n=124) were divided into 2 groups: the main group (66 patients with moderate severity and severe course) and the comparison group (58 patients with a mild form). All patients underwent a screening study of Helicobacter pylori in feces and serological blood test to detect antibodies, namely immunoglobulin M to Helicobacter pylori (determination of the phase of the disease acute or chronic). In 39 (31.5%) patients of the main group, a bacteriological study of biological and biopsy specimens of antral mucous membrane were taken and examined histologically for organisms.
The selection of antibiotics for treatment was carried out taking into account the infection of patients with Helicobacter pylori and was performed using the authors method, the effectiveness of treatment was controlled microbiologically.
Results. The positive result of the express test was in 66 (100%) patients of the main group and in 39 (67.2%) patients in the comparison group. During serological examination, a positive result was obtained: 24 hours after hospitalization in 8 (13.8%) patients in the comparison group, in 23 (34.8%) patients in the main group; after 7 days in 9 (15.5%) patients and 42 (63.3%) patients, respectively. Helicobacter pylori is sensitive to the majority of antibiotics used to treat purulent-septic complications of acute pancreatitis; after finishing the course of antibiotic therapy, eradication was achieved in 37 (94.9%) patients of the main group.
Conclusion. Positive results of a serological study of elicobacter pylori after 7 days from the moment of hospitalization were more common in patients of the main group (63.3%) in relation to the comparison group (15.5%) (χ2=28.9, p<0.001), which gives grounds to consider bacteria, as one of the markers of the development of purulent-septic complications of acute pancreatitis.

Keywords: Helicobacter pylori, acute pancreatitis, etiology, purulent-septic complications, diagnosis, treatment
p. 542-548 of the original issue
  1. Rasslan R, Novo FC, Rocha MC, Bitran A, Rocha MS, Bernini CO, Rasslan S, Utiyama EM. Pancreatic necrosis and gas in the retroperitoneum: treatment with antibiotics alone. Clinics (Sao Paulo). 2017 Feb;72(2):87-94. Published online 2017 Feb. doi: 10.6061/clinics/2017(02)04
  2. Roberts JA, Roger C, De Waele JJ. Personalized antibiotic dosing for the critically ill. Intensive Care Med. 2019 May;45(5):715-18. doi: 10.1007/s00134-019-05522-3
  3. Mowbray NG, Ben-Ismaeil B, Hammoda M, Shingler G, Al-Sarireh B. The microbiology of infected pancreatic necrosis. Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):456-60. doi: 10.1016/j.hbpd.2018.08.007
  4. Moka P, Goswami P, Kapil A, Xess I, Sreenivas V, Saraya A. Impact of antibiotic-resistant bacterial and fungal infections in outcome of acute pancreatitis. Pancreas. 2018 Apr;47(4):489-94. doi: 10.1097/MPA.0000000000001019
  5. Sarsenbaeva AS, Domracheva EV, Rustamov MN. Clinical relevance Helicobacter pylori genotypes in patients with chronic pancreatitis and concomitant infections Helicobacter Pylori. Experimental and Clinical Gastroenterology. 2016;(5):22-27. (In Russ.)
  6. Banić M, Franceschi F, Babić Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 2012 Sep;17(Suppl 1):49-55. doi: 10.1111/j.1523-5378.2012.00983.x
  7. Matrakool L, Tongtawee T, Bartpho T, Dechsukhum C, Loyd RA, Kaewpitoon SJ, Kaewpitoon N. Improved detection of Helicobacter pylori infection and premalignant gastric mucosa using conventional white light source gastroscopy. Asian Pac J Cancer Prev. 2016;17(4):2099-103. doi: 10.7314/apjcp.2016.17.4.2099
  8. Khan J, Pelli H, Lappalainen-Lehto R, Järvinen S, Sand J, Nordback I. Helicobacter pylori in alcohol induced acute pancreatitis. Scand J Surg. 2009;98(4):221-4. doi: 10.1177/145749690909800405
  9. Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2021 Jun;54(3):359-69. doi: 10.1016/j.jmii.2020.08.011
  10. Bulajic M, Panic N, Löhr JM. Helicobacter pylori and pancreatic diseases. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):380-83. doi: 10.4291/wjgp.v5.i4.380
  11. Best LM, Takwoingi Y, Siddique S, Selladurai A, Gandhi A, Low B, Yaghoobi M, Gurusamy KS. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2
  12. Khan J, Pelli H, Lappalainen-Lehto R, Järvinen S, Sand J, Nordback I. Helicobacter pylori in alcohol induced acute pancreatitis. Scand J Surg. 2009;98(4):221-24. doi: 10.1177/145749690909800405
  13. Stepanov YM, Budzak IY. Maastricht consensus-5: analytical review of statements. Gastroenterology, 51(1), 3645. doi: 10.22141/2308-2097.51.1.2017.97870 (In Russ.)
Address for correspondence:
01601, Ukraine, Kiev,
Blvd T.Shevcheko, 13,
A.A. Bogomolets National
Medical University,
the Surgery Department No 2?
tel.: +380 (67) 698 86 17,,
Hanol Ihor V.
Information about the authors:
Kolosovych Ihor V., MD, Professor, Head of the surgery Department No2, A.A. Bogomolets National Medical University, Kiev, Ukrain.
Hanol Ihor V., PhD, Associate Professor of the Surgery Department No2, A.A. Bogomolets National Medical University, Kiev, Ukrain.



Chita State Medical Academy, Chita,
The Russian Federation

Objective. To analyze the frequency of occurrence of eNOS 786C>T, END1 Lys198Ash, ITGB3 1565T>C (Leu33Pro), F5 1691G>A, F2 20210G>A, MMP9 8202A>G, MTHFRA 1298 C,VEGFA 634C>G gene polymorphisms in diabetic foot syndrome.
Methods. The study included patients (n=198) with uncomplicated diabetes mellitus and patients (n=199) with the development of diabetic foot syndrome. Genotyping of the studied gene polymorphisms was performed by the polymerase chain reaction method.
Results. In patients with uncomplicated diabetes mellitus and in patients with diabetic foot, no significant differences were found in the frequency of occurrence of polymorphisms 786C>T of the eNOS3 gene, Lys198Ash of the END1 gene, 1691G>A of the F5 gene, 20210G>A of the F2 gene, 8202A>G of the MMP9 gene, 634C> G of the VEGFA gene and their allelic variants. Associative relationship between the polymorphisms of the NOS 786C>T, END1 Lys198Ash, F5 1691G>A, F2 20210G>A, MMP9 8202A>G, VEGFA 634C>G genes and the development of diabetic foot syndrome was not found. With the development of a diabetic foot, a heterozygous variant of the 1565T polymorphism of the ITGB3 gene was more common than in uncomplicated diabetes mellitus (37.7% and 28.3%, respectively (χ²=6.243, p=0.045)). The risk of developing a diabetic foot with the carriage of this polymorphism is 1.5 times higher than with other variants of gene polymorphism ((OR=1.534 (95% Cl 1.006 2.338), p<0.05). Polymorphism 1298 AS of the MTHFR gene was more often detected in the group of patients with uncomplicated diabetes mellitus than in the group with the development of diabetic foot (45.4% and 29.1%), (χ²=11.55, p=0.004).
Conclusion. The development of diabetic foot syndrome is associated with the carriage of the heterozygous 1565T polymorphism of the ITGB3 gene, in which the likelihood of developing this complication increases 1.5 fold. In diabetes mellitus without complications, a more frequent carriage of the heterozygous polymorphism 1298 AC of the MTHFR gene was revealed, which may have a protective effect against the development of diabetic foot syndrome.

Keywords: diabetic foot, gene polymorphism, vascular tone, platelet receptors, remodeling, prothrombotic factors
p. 549-557 of the original issue
  1. Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014 Dec;42(12):698-702. doi: 10.1016/j.mpmed.2014.09.007
  2. Rundo AI. Some modern aspects of etiology and pathogenesis of diabetic foot syndrome. Novosti Khirurgii. 2015;23(1):97-104.doi: 10.18484/2305-0047.2015.1.97 (In Russ.)
  3. Veves A, Giurini JM, Guzman RJ, eds. The Diabetic Foot. Medical and Surgical Management. 4-th ed. HumanaPress; 2018. 515 . doi: 10.1007/978-3-319-89869-8
  4. Pozhilova EV, Novikov VE. Physiological and pathological value of cellular synthase of nitrogen oxide and endogenous nitrogen oxide. Vestnik SmGMA 2015;14(4):35-41. (In Russ.)
  5. Wang X, Guo Z, Ding Z, Khaidakov M, Lin J, Xu Z, Sharma SG, Jiwani S, Mehta JL. Endothelin-1 upregulation mediates aging-related cardiac fibrosis. J Mol Cell Cardiol.2015 Mar;80:101-9. doi: 10.1016/j.yjmcc.2015.01.001
  6. Zhao S, Li T, Zheng B, Zheng Z. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis. Ophthalmic Genet. 2012 Dec;33(4):200-7. doi: 10.3109/13816810.2012.675398
  7. Muslimova E.F. Association between nos3 and itgb3 polymorphisms and the risk of coronary artery disease. The Siberian Journal of Clinical and Experimental Medicine. 2016;31(2):22-25. (In Russ.) doi: 10.29001/2073-8552-2016-31-2-22-25 (In Russ.)
  8. Šeruga M, Kariž S, Makuc J, Završnik M, Cilenšek I, Gazdikova K, Caprnda M, Kruzliak P, Petrovič D. Endothelin-1 Gene Polymorphisms rs5370, rs1476046, and rs3087459 are not Associated with Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus. Folia Med (Plovdiv). 2017 Sep 1;59(3):261-69. doi: 10.1515/folmed-2017-0033
  9. Yakovleva EV, Konyashina NI, Gorgidze LA, Surin VL, Pshenichnikova OS, Polevodova OA, Spirin MV, Galstyan GM, Zozulya NI. Congenital factor V deficiency: case reports. Russian Journal of Hematology and Transfusiology. 2019;64(4):489503. (In Russ.) doi: 10.35754/0234-5730-2019-64-4-489-503 (In Russ.)
  10. Bogatyreva KB, Azova MM, Aghajanyan AV, Leila V. Tskhovrebova LV, Ait AA, Shugushev ZKh. Association of the ITGB3 gene T1565C polymorphism with the development of atherosclerosis and in-stent restenosis in patients with stable coronary artery disease. Nauchnye Rezultaty Biomed Issledovanii. 2018;4(4):3-9. doi: 10.18413/2313-8955 (In Russ.)
  11. Koloskov AV, Chernova EV. Clinical significance of factor V and prothrombin genes polymorphism. Russian Journal of Hematology and Transfusiology. 2018;63(3):250-257. doi: 10.25837/HAT.2019.63.13.004 (In Russ.)
  12. Omelchenko VO, Letyagina EA, Shevchenko V, Konenkov VI, Pospelova TI, Korolev MA. Association of polymorphisms in the promoter regions of MMP2, MMP3 and MMP9 genes with cardiovascular risk factors in patients with rheumatoid arthritis. J Sib Med Sci. 2019;(1):109-118. doi: 10.31549/2542-1174-2019-1-109-11 (In Russ.)
  13. Sibireva OF, Khitrinskaya EYu, Kalyuzhin VV, Sazonov AE, Ivanchuk II, Grankina VYu. Coagulation factors II,V and methylene tetrahydrofolate reductase gene polymorphism in patients with diabetic nephropathy: prevalence, clinical and prognostic implications. Diabetes Mellitus. 2010;13(1):6-9. doi: 10.14341/2072-0351-6009 (In Russ.)
  14. Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015 Jul 7;132(1):e6-9. doi: 10.1161/CIRCULATIONAHA.114.013311
  15. Singh K, Agrawal NK, Gupta SK, Singh K. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Low Extrem Wounds. 2013 Sep;12(3):199-204. doi: 10.1177/1534734613493289
  16. Bitsadze VO. Samburova NV, Makatsanya NA. Mishchenko AL. Folate deficiency in obstetrics and the problem of its correction. Akusherstvo Ginekologiia i Reproduktsiia. 2016;10(1)1:38-48. doi: 10.17749/2313-7347.2015.10.1.038-048 (In Russ.)
  17. Rahimi M, Hasanvand A, Rahimi Z, Vaisi-Raygani A, Mozafari H, Rezaei M, Zargooshi J, Najafi F, Shakiba E. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem. 2010 Nov;43(16-17):1333-39. doi: 10.1016/j.clinbiochem.2010.08.019
  18. Rusanov AV, Chumachenko IaD, Dubovik EI, Garbuzova VIu, Ataman AV. Analysis of the association between C936T VEGFA gene polymorphism and diabetic foot syndrome in the Ukrainian population. Research Results in Biomedicine. 2019;5(2):34-43. DOI: 10.18413/2658-6533-2019-5-2-0-4 (In Russ.).
  19. Li X, Lu Y, Wei P. Association between VEGF genetic variants and diabetic foot ulcer in Chinese Han population: A case-control study. Medicine (Baltimore). 2018 May;97(20):e10672. doi: 10.1097/MD.0000000000010672
Address for correspondence:
672000, Russian Federation,
Chita, Gorkii Str., 39,
Chita State Medical Academy,
Department of Hospital Surgery,
tel.: +7 924 38045 38,
Troitskaya Natalia I.
Information about the authors:
Troitskaya Natalia I., PhD, Assistant of the Department of Hospital Surgery, Chita State Medical Academy, Chita, Russian Federation.
Shapovalov Konstantin G., MD, Professor, Head of the Department of Anesthesiology, Resuscitation and Intensive Care, Chita State Medical Academy, Chita, Russian Federation. 0000-0002-3485-5176
Mudrov Viktor A., PhD, Associate Professor of the Department of Obstetrics and Gynecology of the Medical and Dental Faculties, Chita State Medical Academy, Chita, Russian Federation.



Peoples Friendship University of Russia (RUDN University),
Burdenko National Medical Research Center of Neurosurgery, Moscow,
The Russian Federation

Objectives. To develop a new system for predicting the outcome of secondary peritonitis and analyze its accuracy in comparison with the most common analogous systems.
Methods. The study is based on the analysis of treatment results in patients (n=352) with secondary peritonitis. At admission sepsis was diagnosed in 15 (4.3%) patients, septic shock in 4 (1.1%) persons. There were the following main causes of death in the mortality structure: purulent intoxication and/or sepsis 51 cases (87.9%), cancer intoxication 4 (6.9%) cases, acute cardiovascular failure 3 cases (5.2%). The efficacy of the Mantheim Peritoneal Index (MPI), WSES prognostic score, APACHE-II scale, gSOFA score and Peritonitis Prediction System (PPS) developed by the authors were analyzed. The likelihood of the effect of 85 clinical and laboratory parameters on the outcome of patients with secondary peritonitis using nonparametric methods of statistical research (Fishers test, Mann-Whitney test, Chi-square with Yates correction) have been analyzed. Criteria predictively associated with lethal outcome (p <0.05) were selected, they were included in the PPS scale. To compare the predictive value of peritonitis prediction systems, ROC analysis was used with the construction of ROC curves for each of the systems.
Results. The most important criteria in predicting fatal outcome are the patients age, the presence of malignant tumor, the exudate nature, sepsis (septic shock), and also polyorganic insufficiency which is not associated with developed peritonitis. To assess the prognostic value of peritonitis prediction systems, ROC curve analysis was used. The greatest accuracy in terms of predicting mortality in patients with generalized secondary peritonitis is possessed by PPS (AUC 0.942), minimal APACHEII (AUC 0.840).
Conclusion. APACHEII, MPI, WSESSSS and PPS systems can be considered as reliable in predicting mortality in patients with peritonitis. The greatest accuracy in predicting fatal outcome in patients with generalized secondary peritonitis had PPS (94%).

Keywords: peritonitis, abdominal sepsis, multiple organ dysfunction, prognosis
p. 558-564 of the original issue
  1. Tolonen M, Coccolini F, Ansaloni L, Sartelli M, Roberts DJ, McKee JL, Leppaniemi A, Doig CJ, Catena F, Fabian T, Jenne CN, Chiara O, Kubes P, Kluger Y, Fraga GP, Pereira BM, Diaz JJ, Sugrue M, Moore EE, Ren J, Ball CG, Coimbra R, Dixon E, Biffl W, MacLean A, McBeth PB, Posadas-Calleja JG, Di Saverio S, Xiao J, Kirkpatrick AW. Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteria. World J Emerg Surg. 2018 Apr;13(1):1-11. doi: 10.1186/s13017-018-0177-2. eCollection 2018.
  2. Sartelli M, Catena F, Abu-Zidan FM, Ansaloni L, Biffl WL, Boermeester MA, Ceresoli M, Chiara O, Coccolini F, De Waele JJ, Di Saverio S, Eckmann C, Fraga G, Giannella M, Girardis M, Griffiths EA, Kashuk JL, Kirkpatrick A, Khokha V, Kluger Y, Labricciosa FM, Leppäniemi A, Vitt Maier R, May AK, Malangoni M, Martin-Loeches I, Mazuski JE, Montravers P, Peitzman A, Tavares Pereira BM, Reis T, Sakakushev B, Sganga G, Soreide K, Sugrue M, Ulrych J, Vincent J-L, Viale P, Moore EE. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg. 2017;12(1):2-31. doi: 10.1186/s13017-017-0132-7
  3. Tolonen M, Sallinen V, Mentula P, Leppäniemi A. Preoperative prognostic factors for severe diffuse secondary peritonitis: a retrospective study. Langenbecks Arch Surg. 2016 Aug;401(5):611-17. doi: 10.1007/s00423-016-1454-8
  4. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287
  5. Kirkpatrick AW, Coccolini F, Ansaloni L, Roberts DJ, Tolonen M, McKee JL, Leppaniemi A, Faris P, Doig CJ, Catena F, Fabian T, Jenne CN, Chiara O, Kubes P, Manns B, Kluger Y, Fraga GP, Pereira BM, Diaz JJ, Sugrue M, Moore EE, Ren J, Ball CG, Coimbra R, Balogh ZJ, Abu-Zidan FM, Dixon E, Biffl W, MacLean A, Ball I, Drover J, McBeth PB, Posadas-Calleja JG, Parry NG, Di Saverio S, Ordonez CA, Xiao J, Sartelli M; Closed Or Open after Laparotomy (COOL) after Source Control for Severe Complicated Intra-Abdominal Sepsis Investigators. Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial. World J Emerg Surg. 2018 Jun 22;13:26. doi: 10.1186/s13017-018-0183-4. eCollection 2018.
  6. Savelev VS, Gelfand BR. (red). Abdominalnaia khirurgicheskaia infektsiia. Natsionalnye rekomendatsii. Moscow, RF: Borges; 2011. 98 p. (In Russ.)
  7. Linder MM, Wacha H, Feldmann U, Wesch G, Streifensand RA, Gundlach E. The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis. Chirurg. 1987 Feb;58(2):84-92.
  8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct;13(10):818-29.
  9. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011 Mar 17;12:77. doi: 10.1186/1471-2105-12-77
Address for correspondence:
117198, Russian Federation,
Moscow, South-Western Administrative District,
Obruchevsky district, Miklukho-Maklay Str., 6, Peoples Friendship University of Russia ,
the Department of Faculty Surgery,
tel.: 8 917-598-9015,
Lebedev Nikolay V.
Information about the authors:
Lebedev Nikolay V., MD, Professor, the Department of Faculty Surgery, Peoples Friendship University of Russia, Moscow, Russian Federation.
Agrba Sariya B., Post-Graduate Student, Burdenko National Medical Research Center of Neurosurgery, Moscow, Russian Federation.
Popov Vasily S., PhD, Assistant, the Department of Faculty Surgery, Peoples Friendship University of Russia, Moscow, Russian Federation.
Klimov Alexey E., MD, Professor, Head of the Department of Faculty Surgery. Peoples Friendship University of Russia, Moscow, Russian Federation.
Svanadze Giorgy T., Post-Graduate Student of the Department of Faculty Surgery, Peoples Friendship University of Russia, Moscow, Russian Federation. /0000-0002-5420-475X




Bogomolets National Medical University,
National Childrens Specialized Hospital Okhmatdet, Kiev,

Objective. To evaluate the results of treatment of prehepatic portal hypertension (PPH) in children by method of side-to-side splenorenal bypass.
Methods. A retrospective, monocentric analysis of 114 patients with prehepatic portal hypertension was carried out in the period from 2000 to 2018. The age of the patients was from 6 months up to 18 years, the average age 10,13,8 years (Mσ). All patients underwent side-to-side splenorenal shunt. In the postoperative period, on the 7th day, ultrasound examination of the abdominal organs with Doppler sonography (US) was performed to assess the volume of the spleen, the rate of portohepatic perfusion, the rate of blood flow along the side-to-side splenorenal shunt, as well as to assess its diameter. Control US was performed after the 1st, 3rd, 6th, 12th months; to assess the regression of esophageal and gastric varicose veins, the control esophagogastroduodenoscopy (EYD) was performed after 3rd , 6th, 12th months and then once a year. Subsequently, the control examination of the patients was carried out once a year. The follow-up was 2-18 years.
Results. Out of 114 patients who underwent side to side splenorenal shunt, 5 (4,4%) patients had recurrent bleeding from the esophageal variceal vein at the follow-up period (2-18 years). One patient had intra-abdominal arrosive bleeding from side-to-side splenorenal shunt provoked by severe postoperative pancreatitis. The average diameter of the shunt was 121.9 mm. The spleen volume decreased by 39.710.3%. Portohepatic perfusion reduced by 39% in comparison with the indicators before surgery. The blood flow rate along the side to-side splenorenal shunt was 2403557.3 ml/min. in 95,4% of patients the regression of variceal vein was noted. Hypersplenism syndrome was arrested in 73.6% of children.
Conclusion. Side -to- side splenorenal shunt is considered to be an effective method of portal decompression with the effectiveness in preventing both esophageal and gastric variceal veins bleeding in 95,4% of patients.

Keywords: portal hypertension, prehepatic type, splenorenal bypass, children, variceal veins, gastrointestinal bleeding
p. 565-572 of the original issue
  1. de Franchis R. Expanding consensus in portal hypertension report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022
  2. Di Salvo Neil, Maffi Michela, Lima Mario. Portal Hypertension in Children. In: Lima M, ed. Pediatric Digestive Surgery. Springer International Publishing; 2017. p. 373-88. doi: 10.1007/978-3-319-40525-4
  3. Aleksandrov AE, Shavrov AA, Seniakovich VM, Leontev AF. Klinika, diagnostika i khirurgicheskoe lechenie detei s portalnoi gipertenziei. Pediatriia. 1999;(2):19-21 (In Russ).
  4. Shneider BL, Bosch J, de Franchis R, Emre SH, Groszmann RJ, Ling SC, Lorenz JM, Squires RH, Superina RA, Thompson AE, Mazariegos GV; expert panel of the Childrens Hospital of Pittsburgh of UPMC. Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant. 2012 Aug;16(5):426-37. doi: 10.1111/j.1399-3046.2012.01652.x
  5. Triana Junco P, Alvarez A, Dore M, Jimenez Gomez J, Sánchez Galán A, Vilanova-Sánchez A, Andres A, Encinas JL, Martinez L, Hernandez F, Lopez Santamaria M. Long-Term Results after Diversion Surgery in Extrahepatic Portal Vein Obstruction. Eur J Pediatr Surg. 2019 Feb;29(1):23-27. doi: 10.1055/s-0038-1668147
  6. Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children. J Am Coll Surg. 2013 Jan;216(1):83-89. doi: 10.1016/j.jamcollsurg.2012.09.013
  7. Shun A, Delaney DP, Martin HC, Henry GM, Stephen M. Portosystemic shunting for paediatric portal hypertension. J Pediatr Surg. 1997 Mar;32(3):489-93. doi: 10.1016/s0022-3468(97)90613-8
  8. Shinde S, Gopalan S, Kandpal DK, Chowdhary SK. Mitra shunt (spleen preserving, side to side lieno-renal shunt) for portal hypertension with hypersplenism in early infancy. J Indian Assoc Pediatr Surg. 2014 Apr;19(2):96-99. doi: 10.4103/0971-9261.129604
  9. Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int. 2018 Feb;12(Suppl 1):148-67. doi: 10.1007/s12072-018-9844-3
  10. El-Karaksy HM, El-Koofy N, Mohsen N, Helmy H, Nabil N, El-Shabrawi M. Extrahepatic portal vein obstruction in Egyptian children. J Pediatr Gastroenterol Nutr. 2015 Jan;60(1):105-9. doi: 10.1097/MPG.0000000000000548
  11. Ling SC. Portal hypertension in children. Clin Liver Dis (Hoboken). 2012 Nov 9;1(5):139-42. doi: 10.1002/cld.79. eCollection 2012 Nov.
  12. Rao KL, Goyal A, Menon P, Thapa BR, Narasimhan KL, Chowdhary SK, Samujh R, Mahajan JK. Extrahepatic portal hypertension in children: observations on three surgical procedures. Pediatr Surg Int. 2004 Sep;20(9):679-84. doi: 10.1007/s00383-004-1272-x
  13. Pal S, Mangla V, Radhakrishna P, Sahni P, Pande GK, Acharya SK, Chattopadhyay TK, Nundy S. Surgery as primary prophylaxis from variceal bleeding in patients with extrahepatic portal venous obstruction. J Gastroenterol Hepatol. 2013 Jun;28(6):1010-14. doi: 10.1111/jgh.12123
  14. Pande GK, Reddy VM, Kar P, Sahni P, Berry M, Tandon BN, Nundy S. Operations for portal hypertension due to extrahepatic obstruction: results and 10 year follow up. Br Med J (Clin Res Ed). 1987 Oct 31;295(6606):1115-17. doi: 10.1136/bmj.295.6606.1115
  15. Orloff MJ, Orloff MS, Girard B, Orloff SL. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years experience with portal-systemic shunt. J Am Coll Surg. 2002 Jun;194(6):717-28; discussion 728-30. doi: 10.1016/s1072-7515(02)01170-5
  16. Lillegard JB, Hanna AM, McKenzie TJ, Moir CR, Ishitani MB, Nagorney DM. A single-institution review of portosystemic shunts in children: an ongoing discussion. HPB Surg. 2010;2010:964597. doi: 10.1155/2010/964597
  17. Haller JD, Glick H, Hallman GL, Cooley DA. Portal decompression by side-to-side splenorenal venous anastomosis. Results in 14 patients. Arch Surg. 1971 Apr;102(4):316-21. doi: 10.1001/archsurg.1971.01350040078015
  18. Aliev MM, Yuldashev RZ, Adilova GS, Yusupaileva GA. Renal blood flow before and after portosystemic shunt in children with portal hypertension. Pediatr Surg Int. 2014 Mar;30(3):295-99. doi: 10.1007/s00383-014-3463-4
Address for correspondence:
01135, Ukraine,
Kiev, st. V. Chornovol 28/1,
National Childrens Specialized Hospital Okhmatdet,
Department of Urgent Surgery,
tel.: +38 067 270-93-23,
Zhezhera Roman V.
Information about the authors:
Zhezhera Roman V., Graduate Student of the Department of Pediatric Surgery, Bogomolets National Medical University, Pediatric Surgeon of the Department of Urgent Surgery, National Childrens Specialized Hospital Okchmatdet.



Odessa National Medical University, Odessa,

Objective. To determine the predictive value of the genetic polymorphism of the N-arylacetyltransferase-2 (NAT-2) gene for assessing the risk of postoperative adhesive intestinal obstruction in children.
Methods. In all children (36 children with adhesive intestinal obstruction (main group) and 35 planned patients (comparative group)) the acetylation genotype was studied by detecting point mutations of the NAT-2 gene using allele-specific amplification method with analysis of a polymerase chain reaction-restriction fragment length polymorphism.
Results. The study of the frequency of mutations at position 481 revealed the greatest diversity of the studied variants of genotypes: 33.3% of the children of the main group were homozygous for the wild-type gene, 44.4% were heterozygotes, 22.2% of patients had a homozygous mutant gene. According to the NAT-2 * 6A genotype (G 590 A), the majority of patients (55.6%) were heterozygotes, 44.4% were homozygotes with the wild-type of the gene. Not a single case of mutation at position 857 has been identified. Among the children of the main group, the share of fast acetylators was 69.4%, in the comparison group 40.0% (χ2=6.215; p=0.013). The development of postoperative adhesive intestinal obstruction in children with the fast acetylation genotype occurred in the absence of clinical and anamnestic risk factors and was characterized by a greater severity and prevalence of intra-abdominal adhesive process (PAI was (14.81.8) and (8.12.4 ), respectively).
Conclusion. The risk of developing postoperative adhesive complications in children can be done preventively by determining the genetic polymorphism of the N-acetyltransferase-2 gene. The risk group for developing adhesive intestinal obstruction is made up of children who are the carriers of NAT-2 alleles and correspond to the genotype of fast and moderate acetylation. Children who are fast acetylators have a more pronounced intra-abdominal adhesion process and a higher risk of complications associated with excessive adhesion even in the absence of other risk factors.

Keywords: adhesive obstruction, adhesions, genetic polymorphism, acetylation genotype, prediction
p. 573-580 of the original issue
  1. Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. World J Gastroenterol. 2011 Nov 7;17(41):4545-553. doi: 10.3748/wjg.v17.i41.4545
  2. Fortin CN, Saed GM, Diamond MP. Predisposing factors to post-operative adhesion development. Hum Reprod Update. 2015 Jul-Aug;21(4):536-51. doi: 10.1093/humupd/dmv021
  3. Voskanyan SE, Kyzlasov PS. Pathogenesis of adhesions formation after intraabdominal operations. Pat Fiziologiia i Eksperim Terapiia. 2011;(4):17-21. (In Russ.)
  4. Lavreshin PM, Gobejishvili VK,Gobejishvili VV,.Kelasov IG. The predictions and prophylaxis of intraabdominal adhesion in patients with acute intesninal non-tumor obstruction. Vestn Eksperim i Klin Khirurgii. 2012;5(1):65-70. doi: 10.18499/2070-478X-2012-5-1-65-70 (In Russ.)
  5. Doll MA, Hein DW. Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Anal Biochem. 2001 Jan 1;288(1):106-8. doi: 10.1006/abio.2000.4892
  6. Hernández-González O, Ortiz-Zamudio JJ, Rodríguez-Pinal CJ, Alvarado-Morales I, Martínez-Jiménez VDC, Salazar-González RA, Correa-González LC, Gómez R, Portales-Pérez DP, Milán-Segovia RDC. Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia. Leuk Lymphoma. 2018 Aug;59(8):1968-975. doi: 10.1080/10428194.2017.1406090
  7. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42.
  8. Todoriko LD, Antonenko PB, Kuzhko MM, Semianov IO, Tlustova TV. Influence of GSTM1 and NAT2 deletion polymorphism on efficiency of TB reatment and selection of way of administration of anti-TB reparations. nfuzia & Khmoterapia. 2019;(1):9-16. doi: 10.32902/2663-0338-2019-19-1-9-16 (In Ukr.)
  9. Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One. 2011 Apr 6;6(4): e18507. doi: 10.1371/journal.pone.0018507
  10. Kresyun VJ, hlnychenko G, Antonenko PB, ntonenko , vashnina .. Adhesion ileus in children in the connective tissues dysplasia. Kln Khrurgia. 2016;(10):21-25. (In Ukr.)
  11. Ten Broek RPG, Krielen P, Di Saverio S, Coccolini F, Biffl WL, Ansaloni L, Velmahos GC, Sartelli M, Fraga GP, Kelly MD, Moore FA, Peitzman AB, Leppaniemi A, Moore EE, Jeekel J, Kluger Y, Sugrue M, Balogh ZJ, Bendinelli C, Civil I, Coimbra R, De Moya M, Ferrada P, Inaba K, Ivatury R, Latifi R, Kashuk JL, Kirkpatrick AW, Maier R, Rizoli S, Sakakushev B, Scalea T, Søreide K, Weber D, Wani I, Abu-Zidan FM, DeAngelis N, Piscioneri F, Galante JM, Catena F, van Goor H. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 2018 Jun 19;13:24. doi: 10.1186/s13017-018-0185-2. eCollection 2018.
  12. Beyene RT, Kavalukas SL, Barbul A. Intra-abdominal adhesions: Anatomy, physiology, pathophysiology, and treatment. Curr Probl Surg. 2015 Jul;52(7):271-319. doi: 10.1067/j.cpsurg.2015.05.001
  13. Atta HM. Prevention of peritoneal adhesions: a promising role for gene therapy. World J Gastroenterol. 2011 Dec 14;17(46):5049-58. doi: 10.3748/WJG.V17.I46.5049
Address for correspondence:
65000, Ukraine,
Odessa, Valikhovsky Lane, 2,
Odessa National Medical University,
Pediatric Surgery Department,
tel. +38050 197-61-85,
Melnychenko Maryna G.
Information about the authors:
Melnychenko Maryna G., MD, Professor of the Pediatric Surgery Department, Odessa National Medical University, Odessa, Ukraine.
Kvashnina Anastasiia A., Postgraduate Student of the Pediatric Surgery Department, Odessa National Medical University, Odessa, Ukraine.
Antonenko Petr B., MD, Professor of the Department of Pharmacology and Pharmacognosy, Odessa National Medical University, Odessa, Ukraine.
Antonenko Kateryna A, PhD, Assistant of the Department of Pharmacology and Pharmacognosy, Odessa National Medical University, Odessa, Ukraine.




Institute of Traumatology and Orthopedics of NAMS of Ukraine 1, Kiev, Ukraine
Republican Scientific and Practical Center of Traumatology and Orthopedics 2, Minsk
The Republic of Belarus

Objective. To assess the variability of the anterolateral ligament according to MRT and ultrasonography data and to coordinate it with surgical treatment strategy for its injuries.
Methods. The anterolateral ligament was analyzed on 100 series of MRI images of knee joints without traumatic pathology on Philips Achieva 1.5 T tomograph using the standard research protocol in three mutually perpendicular planes and 150 series of MRT images of knee joints with injuries and without injuries of the anterolateral ligament obtained on different tomographs from 0.2 to 3 Tesla. The quality of visualization of anterolateral ligament separate portions, the number of layers, and the contact with the joint capsule were evaluated. Both knee joints were analyzed by ultrasonography in 30 patients with anterior cruciate ligament injuries of one of the knee-joint and in 30 patients with intact knee-joints.
Results. During the studies in the identification of anterolateral ligament with magnetic resonance tomography (MRT 1.5T) it was revealed at least partially in 92% of cases (in 68% as a two-layer structure; in 24% as a single-layer structure; in 14% as a thickening of the capsule or in 10% as a separate extracapsular structure), ultrasound examination in 100% (the structure was not determined, however, in 26.67% of patients without clinically pronounced pathology of the knee-joint and significant trauma in anamnesis ultrasound scan revealed a violation of the integrity of the cortical layer at the tibial attachment site),
Conclusion. According to MRT and ultrasonography data, the anterolateral ligament is a constant structure of the knee-joint, but very variable in its anatomical parameters, which in some cases may be poorly visualized on MRT, may have a two-layer structure, may be located either extracapsular or as a thickening of the knee-joint capsule. The variability of its anatomical structure makes it impossible to make the theoretical substantiation of the advantages of one separate method of its restoration, but, on the contrary, justifies a differentiated approach to the selection of optimal surgical treatment.

Keywords: anterolateral ligament, anterolateral complex, knee joint, rotational instability, MRT, ultrasonography, surgical treatment
p. 581-589 of the original issue
  1. Claes S, Vereecke E, Maes M, Victor J, Verdonk P, Bellemans J. Anatomy of the anterolateral ligament of the knee. J Anat. 2013 Oct;223(4):321-28. doi: 10.1111/joa.12087
  2. Vieira EL, Vieira EA, da Silva RT, Berlfein PA, Abdalla RJ, Cohen M. An anatomic study of the iliotibial tract. Arthroscopy. 2007 Mar;23(3):269-74. doi: 10.1016/j.arthro.2006.11.019
  3. Lee DW, Lee JH, Kim JN, Moon SG, Kim NR, Kim DH, Kim JG. Evaluation of anterolateral ligament injuries and concomitant lesions on magnetic resonance imaging after acute anterior cruciate ligament rupture. Arthroscopy. 2018 Aug;34(8):2398-406. doi: 10.1016/j.arthro.2018.02.048
  4. Fardin PBA, Lizardo JHF, Baptista JDS. Study of the anterolateral ligament of the knee in formalin-embedded cadavers. Acta Ortop Bras. 2017 Mar-Apr;25(2):89-92. doi: 10.1590/1413-785220172502162204
  5. Bonasia DE, DAmelio A, Pellegrino P, Rosso F, Rossi R. Anterolateral ligament of the knee: back to the future in anterior cruciate ligament reconstruction. Orthop Rev (Pavia). 2015 Jun 11;7(2):5773. doi: 10.4081/or.2015.5773. eCollection 2015 Jun 3.
  6. DePhillipo NN, Cinque ME, Chahla J, Geeslin AG, LaPrade RF. Anterolateral ligament reconstruction techniques, biomechanics, and clinical outcomes: a systematic review. Arthroscopy. 2017 Aug;33(8):1575-83. doi: 10.1016/j.arthro.2017.03.009
  7. LaPrade RF. Editorial commentary: defining the anatomy of the anterolateral aspect of the knee among experts is clearly needed. Arthroscopy. 2016 May;32(5):842-43. doi: 10.1016/j.arthro.2016.03.002
  8. Ferretti A. Extra-articular reconstruction in the anterior cruciate ligament deficient knee: a commentary. Joints. 2014 Jan-Mar;8;2(1):41-47. eCollection 2014 Jan-Mar.
  9. Ibrahim SA, Shohdy EM, Marwan Y, Ramadan SA, Almisfer AK, Mohammad MW, Abdulsattar WS, Khirat S. Anatomic reconstruction of the anterior cruciate ligament of the knee with or without reconstruction of the anterolateral ligament: a randomized clinical trial. Am J Sports Med. 2017 Jun;45(7):1558-66. doi: 10.1177/0363546517691517
  10. Helito CP, do Amaral C Jr, Nakamichi YD, Gobbi RG, Bonadio MB, Natalino RJ, Pécora JR, Cardoso TP, Camanho GL, Demange MK. Why do authors differ with regard to the femoral and meniscal anatomic parameters of the knee anterolateral ligament?: dissection by layers and a description of its superficial and deep layers. Orthop J Sports Med. 2016 Dec 22;4(12):2325967116675604. doi: 10.1177/2325967116675604
  11. Cho HJ, Kwak DS. Anatomical consideration of the anterolateral ligament of the knee. Biomed Res Int. 2019 Apr 11;2019:5740473. doi: 10.1155/2019/5740473. eCollection 2019.
  12. Kennedy MI, Claes S, Fuso FA, Williams BT, Goldsmith MT, Turnbull TL, Wijdicks CA, LaPrade RF. The Anterolateral ligament: an anatomic, radiographic, and biomechanical analysis. Am J Sports Med. 2015 Jul;43(7):1606-15. doi: 10.1177/0363546515578253
  13. Runer A, Birkmaier S, Pamminger M, Reider S, Herbst E, Künzel KH, Brenner E, Fink C. The anterolateral ligament of the knee: A dissection study. Knee. 2016 Jan;23(1):8-12. doi: 10.1016/j.knee.2015.09.014
  14. Faruch Bilfeld M, Cavaignac E, Wytrykowski K, Constans O, Lapègue F, Chiavassa Gandois H, Larbi A, Sans N. Anterolateral ligament injuries in knees with an anterior cruciate ligament tear: Contribution of ultrasonography and MRI. Eur Radiol. 2018 Jan;28(1):58-65. doi: 10.1007/s00330-017-4955-0
  15. Panda S, Sravanthi J, Kejriwal GS, Madhavi C. Evaluation of Anterolateral Ligament of Knee Using USG and MRI in Cases of Anterior Cruciate Ligament Tear. Int J Anat Radiol Surg. 2020;9(1):RO16-RO19. doi: 10.7860/IJARS/2020/42797:2531
  16. Sonnery-Cottet B, Daggett M, Fayard JM, Ferretti A, Helito CP, Lind M, Monaco E, de Pádua VBC, Thaunat M, Wilson A, Zaffagnini S, Zijl J, Claes S. Anterolateral Ligament Expert Group consensus paper on the management of internal rotation and instability of the anterior cruciate ligament deficient knee. J Orthop Traumatol. 2017 Jun;18(2):91-106. doi: 10.1007/s10195-017-0449-8
  17. Young BL, Ruder JA, Trofa DP, Fleischli JE. Visualization of concurrent anterolateral and anterior cruciate ligament injury on magnetic resonance imaging. Arthroscopy. 2020 Apr;36(4):1086-91. doi: 10.1016/j.arthro.2019.09.039
Address for correspondence:
01601 Ukraine,
Kiev, Bulvarno-Kudryavskaya Str., 27,
Institute of Traumatology and Orthopedics,
the Department of Sports and Ballet Trauma
of NAMS of Ukraine,
tel. +38(068)321 42 87.
Kotiuk Viktor V.
Information about the authors:
Kostrub Oleksandr O., MD, Professor, Head of the Department of Sports and Ballet Trauma, Institute of Traumatology and Orthopedics of NAMS of Ukraine, Kiev, Ukraine.
Poliachenko Iurii V., MD, Professor, Acting Director of Institute of Traumatology and Orthopedics of NAMS of Ukraine, Kiev, Ukraine
Gerasimenko Mikhail A., MD, Professor, Director of Republican Scientific and Practical Center of Traumatology and Orthopedics, Minsk, Republic of Belarus
Kotiuk Viktor V., PhD, Senior Researcher of the Department of Sports and Ballet Trauma, Institute of Traumatology and Orthopedics of NAMS of Ukraine, Kiev, Ukraine.
Blonskii Roman I., MD, Leading Researcher of the Department of Sports and Ballet Trauma, Institute of Traumatology and Orthopedics of NAMS of Ukraine, Kiev, Ukraine.
Mazevych Vadym B., Researcher of the Diagnostics Department, Institute of Traumatology and Orthopedics of NAMS of Ukraine, Kiev, Ukraine.
Vadzyuk Nazar S., PhD, Senior Researcher of the Department of Sports and Ballet Trauma, Institute of Traumatology and Orthopedics of NAMS of Ukraine, Kiev, Ukraine.




Mogilev Regional Hospital, Mogivev,
The Republic of Belarus

Objective. To evaluate the efficacy of tranexamic acid () in cardiac surgery patients undergoing the open-heart surgery under conditions of artificial blood circulation (BC) by determining the volume of perioperative blood loss using the hemoglobin balance method.
Methods. A pilot non-randomized prospective clinical trial was conducted. To determine the effectiveness of T use, 2 groups of patients were formed: the 1st group, without T application (n=40), the 2nd group with T application intraoperatively (n=40). In group 2, prior to sternotomy, intravenous bolus injection of TA (1000 mg (20 ml of 5% solution)) was performed and further titration of TA through a syringe dispenser was continued at a rate of 4 ml/hour (200 mg/hour) until the end of the operation.The volume of intraoperative blood-loss was assessed by the hemoglobin balance method. A special protocol was developed to control the volume of postoperative blood loss.
Results. The volume of circulating blood (VCB) calculated by Nadlers formula for the first group was 5433.2 (5008.5; 5768.2) ml, for the second 5214.0 (4944.1; 5546.8) ml. In the first group of patients who did not receive TA during open- heart surgery, the volume of blood loss was 1460.6 (1196.8; 1725.8) ml or 26.9 % of the average circulating blood volume (CBV), and in the second group of patients who received TA intraoperatively 1090.7 (882.3; 1468.6) ml or 20.9% of the CBV (p<0,001).
Conclusion. The application of T in cardiac surgery patients during open-heart surgery with ABC according to the developed algorithm (1000 mg/bolus, titration during surgery-200 mg/h) for the purpose of blood saving the volume of blood-loss was reduced by 25.3% compared to the control group.

Keywords: cardiac surgery, tranexamic acid, blood loss, hemoglobin balance, extracorporeal circulation
p. 590-597 of the original issue
  1. Ostrovskii IuP, Valentiukevich AV, Zhigalkovich AS. Kardiokhirurgiia: spravochnik. Moscow, RF: Med lit; 2014. p.122-130. 512 p. (In Russ.)
  2. Khensli-ml FA, Martin DE, Grevli GP. Prakticheskaia kardioanesteziologiia: per s angl. 3-e izd. Moscow, RF: MIA; 2008. 1104 p. (In Russ.)
  3. Dementeva II, Morozov IuA, Charnaia MA. Gl. 9. Diagnostika, profilaktika i korrektsiia narushenii sistemy gomeostaza v kardoikhirurgii. V kn: Buniatian AA, Trekova NA, Eremenko AA, red. Rukovodstvo po kardioanesteziologii i intensivnoi terapii. Moscow, RF: MIA; 2015. p. 225-51. (In Russ.)
  4. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013 Jun;30(6):270-82. doi: 10.1097/EJA.0b013e32835f4d5b
  5. Gao FQ, Li ZJ, Zhang K, Sun W, Zhang H. Four methods for calculating blood-loss after total knee arthroplasty. Chin Med J (Engl). 2015 Nov 5;128(21):2856-60. doi: 10.4103/0366-6999.168041
  6. Samuel B Nadler, John H Hidalgo, Ted Bloch. Prediction of blood volume in normal human adults. Surgery. 1962 Feb;51(2):224-32.
  7. Trekova NA, Charchian ER, Akselrod BA, Seleznev MN, Guskov DA, Soloveva IN. Sovremennye tekhnologii sokhraneniia krovi bolnogo i snizheniia ispolzovaniia donorskoi krovi pri operatsiiakh na voskhodiashchei aorte i duge aorty. Anesteziologiia i Reanimatologiia [Elektronnyi resurs]. 2015 Sent [data obrashcheniia: 2019 Okt 17];60(5):20-26. Available from: (In Russ.)
  8. Trekova NA, Ivanov VA, Solovova LYe, Alekseyeva LA, Zaitscva SV. Ways of reducing donor blood components at surgery under extracorporeal circulation. Anesteziologiia i Reanimatologiia. 2008;(5):36-40. (In Russ.)
  9. Zenkov AA, Ostrovskii IuP, Vykhristenko KS, Loiko NG. Sravnitelnyi analiz rezultatov miniinvazivnoi revaskuliarizatsii miokarda, koronarnogo shuntirovaniia na rabotaiushchem serdtse i s iskusstvennym krovoobrashcheniem. Novosti Khirurgii. 2014;22(1):33-43. doi: 10.18484/2305-0047.2014.1.33 (In Russ.)
  10. Trekova NA, Solovova LE, Guskov DA, Soloveva IN, Markin AV, Goloborodko VG, Panin VV. Transfuzionnaia taktika pri operatsiiakh na serdtse i aorte. Anesteziologiia i Reanimatologiia [Elektronnyi resurs]. 2014 [data obrashcheniia: 2020 Ianv 22];(3):4-10. Available from: (In Russ.)
  11. Hodgson S, Larvin JT, Dearman C. What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2015 Sep;21(3):384-88. doi: 10.1093/icvts/ivv134
  12. Guo J, Gao X, Ma Y, Lv H, Hu W4, Zhang S, Ji H, Wang G, Shi J. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiology. 2019 Jul 15;19(1):129. doi: 10.1186/s12871-019-0772-0
Address for correspondence:
212016, Republic of Belarus,
Mogilev, Belynitskogii-Biruli Str.,
Mogilev Regional Hospital, Intensive Care
Unit of the Center of Cardiovascular Surgery,
tel/fax +375 222 62-90-75,
Bodyakov Kirill V.
Information about the authors:
Bodyakov Kirill V., Anaesthesiologist of the Intensive Care Unit of the Center of Cardiovascular Surgery, Mogilev Regional Hospital, Mogilev, Republic of Belarus.
Marochkov Alexey V., MD, Professor, Anaesthesiologist of the Intensive Care Unit, Mogilev Regional Hospital, Mogilev, Republic of Belarus.
Kylik Anatoly S., Cardiac Surgeon, Head Physician, Mogilev Regional Hospital, Mogilev, Republic of Belarus.
Dudko Vladimir A., Head of the Intensive Care Unit of the Center of Cardiovascular Surgery, Mogilev Regional Hospital, Mogilev, Republic of Belarus.
Lipnitski Artur L., PhD, Head of the Department for Coordinating the Collection of Organs and Tissues for Transplantation, Mogilev Regional Hospital, Mogilev, Republic of Belarus.




Vitebsk State Medical University 1,Vitebsk,
Belarusian Medical Academy of Postgraduate Education 2, Minsk
The Republic of Belarus

Acute necrotizing pancreatitis (ANP) is associated with significantly higher morbidity and mortality. It is still difficult for the surgeon to choose and schedule the most appropriate treatment. In the early phase of the disease, surgical activity is considered to be ineffective and is associated with high risks. The only chance to save the patient is to conduct the intensive therapy in the intensive care unit, based on current pathogenetic approaches. The present review analyzed the current understanding of the pathogenesis of multiple organ dysfunction syndrome (MODS) in acute necrotizing pancreatitis. he role of inflammatory mediators, cytokines, biogenic amines, bradykinins, and lipid peroxidation products in the development of organ hypoperfusion is reflected. It is shown that the violation of the intestinal barrier function with the translocation of microorganisms exacerbates endogenous intoxication and contributes to the development of MODS. The endothelial dysfunction that develops in acute necrotizing pancreatitis has a significant effect on hemostasis. The literature analysis revealed the contradictory data on the functional activity of the coagulation and anticoagulation systems at different stages of the disease. The mechanisms of development of intra-abdominal hypertension and its multisystem negative impact are reflected. There are still controversial question of appropriate timing and indications for surgical decompression.
The analysis of the available literature data showed the need for further study of the mechanisms of multiple organ dysfunction development in acute necrotizing pancreatitis to work out new pathogenetically justified methods of its intensive therapy with an assessment of their effectiveness.

Keywords: acute necrotizing pancreatitis, multiple organ failure, endogenous intoxication, systemic inflammatory reaction, intra-abdominal hypertension, changes in hemostasis
p. 598-606 of the original issue
  1. Alimova KP, Alibekova MB. Polyorganic insufficiency, problems and modern methods of treatment. Vestn Ekstrennoi Meditsiny. 2019;12(1):75-80. (In Russ.)
  2. Munigala S, Yadav D. Case-fatality from acute pancreatitis is decreasing but its population mortality shows little change. Pancreatology. 2016 Jul-Aug;16(4):542-50. doi: 10.1016/j.pan.2016.04.008
  3. Kurti F, Shpata V, Kuqo A, Duni A, Roshi E, Basho J. Incidence of acute pancreatitis in Albanian population. Mater Sociomed. 2015 Dec;27(6):376-79. doi: 10.5455/msm.2015.27.376-379
  4. Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry N, Sartelli M, Wolbrink D, van Goor H, Baiocchi G, Ansaloni L, Biffl W, Coccolini F, Di Saverio S, Kluger Y, Moore E, Catena F. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019 Jun 13;14:27. doi: 10.1186/s13017-019-0247-0. eCollection 2019.
  5. Gelfand BR, Zabolotskikh IB. Intensivnaia terapiia. Natsionalnoe rukovodstvo. Moscow, RF: GEOTAR-Media; 2017. 928 p. (In Russ.)
  6. Schlyakhova MA, Marijko VA, Kazakov MS. Analysis of the actual state of mortality from acute pancreatitis. Vestn Novykh Med Tekhnologii. 2019;26(4):66-70. doi: 10.24411/1609-2163-2019-16583. (In Russ.)
  7. Beburishvil AG, Burchuladze NSh, Mazunov AS. Features of early systemic complications in patients with destructive pancreatitis. Vestn VolgGMU. 2017;(2):52-55. doi: 10.19163/1994-9480-2017-2(62)-52-55. (In Russ.)
  8. Goltsov VR, Savello VE, Bakunov AM, Dymnikov DA, Kurochkin DM, Batig EV. Purulent-necrotic parapancreatitis: the evolution of views on treatment. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2015;20(3):75-83. doi: 10.16931/1995-5464.2015375-83 (In Russ.)
  9. Dibirov MD. Domarev LV. Shitikov EA, Isayev AI. Karsotiyan GS. Principles cliff pancreatic necrosis in a first-aid hospital . Khirurgiia Zhurn im NI Pirogova. 2017;(1):73-78. doi: 10.17116/hirurgia2017173-77 (In Russ.)
  10. Martin-Loeches I, Levy MM, Artigas A. Management of severe sepsis: advances, challenges, and current status. Drug Des Devel Ther. 2015 Apr 9;9:2079-88. doi: 10.2147/DDDT.S78757. eCollection 2015.
  11. Faraj TA, McLaughlin CL, Erridge C. Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection. Int Rev Immunol. 2017 May 4;36(3):125-44. doi: 10.1080/08830185.2017.1280483
  12. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):775-87. doi: 10.1001/jama.2016.0289
  13. Ostrovsky VK, Rodionov PN, Makarov SV. Severity assessment and prognosis definition in patients with the acute pancreatitis. Khirurgiia Zhurn im NI Pirogova. 2011;(8):58-60. p-/khirurgiya-zhurnal-im-n-i-pirogova/2011/8/030023-12072011810 (In Russ.)
  14. Ermolov AS, Ivanov PA, Blagovestnov DA, Grishin AA, Andreev VG. Diagnostika i lechenie ostrogo pankreatita. Moscow, RF: VIDAR; 2013. 384 p. (In Russ.)
  15. Lebedev NV, Klimov AE. Sistemy otsenok tiazhesti sepsisa i endogennoi intoksikatsii. Khirurgiia. Zhurn im NI Pirogova. 2006;(5):53-56. (In Russ.)
  16. Khoroshilov SE, Nikulin AV. Efferent treatment for critical conditions. General Reanimatology. 2012;8(4):30. doi: 10.15360/1813-9779-2012-4-30 (In Russ.)
  17. Agayev BA.. Djafarly ZE. Treatment of the acute pancreatitis. Khirurgiia Zhurn im NI. Pirogova. 2010;(4):63-66. ttps:// (In Russ.)
  18. Galperin EI, Diuzheva TG, Dokuchaev KV, Pogosian GS, Chevokin AIu, Akhaladze GG, Abdel-Galil R. Diagnostika i khirurgicheskoe lechenie pankreonekroza. Vestn Khirurgii im II Grekova. 2003;162(3):55-59. (In Russ.)
  19. Uomo G, Gallucci F, Madrid E, Miraglia S, Manes G, Rabitti PG. Pancreatic functional impairment following acute necrotizing pancreatitis: long-term outcome of a non-surgically treated series. Dig Liver Dis. 2010 Feb;42(2):149-52. doi: 10.1016/j.dld.2009.08.007
  20. Datsuk AI, Shlapak IP, Titarenko NV. 10 year experience in treatment and prevention of multiple organ failure due to severe acute pancreatitis: 223 cases study. Vestn Intensiv Terapii. 2013;(2):19-26. (In Russ.)
  21. Mole DJ, Andrew Hall A, McKeown D, Garden OJ, Parks RW. Detailed fluid resuscitation profiles in patients with severe acute pancreatitis. HPB (Oxford). 2011 Jan;13(1):51-58. doi: 10.1111/j.1477-2574.2010.00241.x
  22. Blaser Reintam A, Poeze M, Malbrain ML, Björck M, Oudemans-van Straaten HM, Starkopf J; Gastro-Intestinal Failure Trial Group. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intensive Care Med. 2013 May;39(5):899-909. doi: 10.1007/s00134-013-2831-1
  23. Varganov MV, Trelyakov EV, Styzhkina SN Nazarov SB. Impact imminomodilators in combined therapy of pancreatic necrosis on the barrier properties of the intestinal mucosa. Sovrem Problemy Nauki i Obrazovaniia. 2012;(3):68-72. (In Russ.)
  24. Aleksandrova IV, Ilinskiy ME, Rey SI, Kiselev VV, Larionov IYu. Early progressive organ failure in patients with severe acute pancreatitis. Khirurgiia Zhurn im NI Pirogova. 2013;(9):29-33. Russ.)
  25. Monahan LJ. Acute respiratory distress syndrome. Curr Probl Pediatr Adolesc Health Care. 2013 Nov-Dec;43(10):278-84. doi: 10.1016/j.cppeds.2013.10.004
  26. Nikiforov YuV. Mikhailusov SV, Moiseenkova YeV. Yiidin Ayu,. Vorykhanov AV, Chirkov AV. Complex treatment for sterile pancreonccrosis. Obshch Reanimatologiia. 2009;5(3):57-64. doi: 10.15360/1813-9779-2009-3-579 (In Russ.)
  27. Powell JJ, Fearon KC, Siriwardena AK, Ross JA. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery. 2001 May;129(5):633-40. doi: 10.1067/msy.2001.113375
  28. Tagozhonov ZF, Panchenko VI, Zholborsov IaZh. Diagnostika i korrektsiia narushenii gemostaza pri ostrom pankreatite. Vestn Intensiv Terapii. 2009;(2):82-85. (In Russ.)
  29. Tseimakh EA, Bombizo VA, Meliksetian AD, Buldakov PN, Orekhov DA. Korrektsiia koaguliantnoi i proteoliticheskoi aktivnosti fagotsitov u bolnykh pankreonekrozom. Annaly Khirurgii. 2010;(5):52-57. (In Russ.).)
  30. Matveyev SB, Fedorova NV, Godkov MA. Evaluation of endogenous intoxication from average molecular weight peptides in emergencies. Klin Lab Diagnostika. 2009;(5):16-18. (In Russ.)
  31. Andreev VA, Karpishchenko AI. Meditsinskaia laboratornaia diagnostika. Programmy i algoritmy. Moscow, RF: GEOTAR-Media; 2014. 696 p. (In Russ.)
  32. Kostiuchenko AL, Filin VN. Neotlozhnaia pankreatologiia. S-Petersburg, RF: Dean; 2000. 480 p. (In Russ.)
  33. Nesterenko IuA, Laptev VV, Mikhailusov SV (red). Diagnostika i lechenie destruktivnogo pankreatita. Moscow, RF: Binom-press; 2004. 304 p. (In Russ.)
  34. Alekseeva LA, Ragimov AA. DVS-sindrom: ruk. Moscow, RF: GEOTAR-Media; 2010. 120 p. (In Russ.)
  35. Korymasov EA, Dzharar RM, Gorbunov YuV, Khaydarov VV. Early diagnosis of DIC in patients with severe acute pancreatitis. Vestn Eksperim i Klin Khirurgii. 2011;4(2):279-82. doi: 10.18499/2070-478X-2011-4-2-272-282. (In Russ.)
  36. Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie. 2010 Jan;30(1):10-2, 14-6. doi: 10.1055/s-0037-1617143
  37. Zhang XP, Li ZJ, Zhang J. Inflammatory mediators and microcirculatory disturbance in acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2009 Aug;8(4):351-57.
  38. van Hinsbergh VW. Endothelium--role in regulation of coagulation and inflammation. Semin Immunopathol. 2012 Jan;34(1):93-106. doi: 10.1007/s00281-011-0285-5
  39. Jarar RR, Korymasov EA, Gorbunov IuV. Korrektsiia sistemy gemostaza v lechenii rannei stadii ostrogo pankreatita. Novosti Khirurgii. 2011;19(2):43-49. (In Russ.)
  40. Elmas E, Suvajac N, Jilma B, Weiler H, Borggrefe M, Dempfle CE. Factor V Leiden mutation enhances fibrin formation and dissolution in vivo in a human endotoxemia model. Blood. 2010 Aug 5;116(5):801-5. doi: 10.1182/blood-2009-03-213215
  41. Vlasov AP, Anaskin SG, Nikolaev EA, Polozova EI, Potyanova IV, Tingayev SV. The coagulative and lytic condition under acute pancreatitis. Fundam Issledovaniia. 2012;(8 ch 2):289-93. (In Russ.)
  42. Gritsan AI, Gritsan GV, Kolesnichenko AP, Odintsova TL. Hemostatic system impairments and principles of their correction in patients with acute abdominal surgical pathology. Vestn Anesteziologii i Reanimatologii. 2010;7(2):20-26. (In Russ.)
  43. Jarar RM. Malfunction peculiarities of the hemostasis system in patients with severe acute pancreatitis.Aspirant Vestn Povolzhia. 2010;10(7-8):166-70. 10.17816/2072-2354.2010.0.7-8.166-170 (In Russ.)
  44. Schlvakhova MA, Bronshte1n PC. Kudryavtseva EV, Ivanova VI. Changes of quantitative and qualitative characteristics of periferic blood of thrombocytes in the patients with pancreonecrosis. Vestn Novykh Med Tekhnologii. 2013;20(3):102-04. (In Russ.)
  45. Zubritskiy VF, Zabelin MV, Koltovich AP , Levchuk AL, Airapetyan AT , Golubev IV, Rozberg EP, Korenev DN. Intraabdominal hypertension and pancreatogenic peritonitis. Annaly Khirurg Gepatologii. 2016;21(4):41-46. 10.16931/1995-5464.2016441-46 (In Russ.)
  46. Nikitina KV, Samsonova I.M Correlation of intraabdominal pressure with indicators of blood gases, acid-base balance and frequency of mechanical lung ventilation in patients with acute destructive pancreatitis. (In Russ.)
  47. Vinnik IuS, Tepliakova OV. Znachenie intraabdominalnoi gipertenzii u bolnykh s ostrym pankreatitom. Vestn Khirurgii im II Grekova. 2016;175(5):110-13. (In Russ.)
Address for correspondence:
210023, Republic of Belarus,
Vitebsk, Frunze Avenue, 27,
Vitebsk State Medical University,
the Department of Anesthesiology and Resuscitation with the Course of Advanced Training and Retraining
tel. mobilr: +375 (33) 316-10-25,
Nikitina Ekaterina V.
Information about the authors:
Nikitsina Katsiaryna V., PhD, Associate Professor, Head of the Department of Anesthesiology and Resuscitation with the Course of Advanced Training and Retraining, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
Ilukevich Georgy V., MD, Professor, Head of the Department of Anesthesiology and Resuscitation, Belarusian Medical Academy of Postgraduate Education, Minsk, Republic of Belarus.



Avicenna Tajik State Medical University, Dushanbe,
The Republic of Tajikistan

This review is devoted to the relevance of the problem and the assessment of potential surgical indications, surgical methods and clinical results in the intestinal autotransplantation. Radical resection of the neoplasm is performed. Currently, the main indications for performing intestinal autotransplantation are considered neoplasms of the pancreas, mesenteric and retroperitoneal space with the involvement of the superior mesenteric vessels in the process. Preliminary results demonstrate that radical resection can be effective in carefully selected patients. Although perioperative morbidity and mortality are relatively high, the literature describes some cases with long patient survival, especially when performing radical resection of a benign tumor or a tumor of potential low malignant. However, early tumor recurrence remains a serious problem in patients with a high-grade tumor, especially with pancreatic ductal adenocarcinoma (PDAC). It should be noted that when using intestinal autotransplantation, it is possible to perform a radical resection of the organ in patients with separate neoplasms in the abdominal cavity and the involvement of the main mesenteric vessels in the process. However, this aggressive method is associated with significant operational risk and should be only performed in specialized centers. The additional combination therapies have to be developed to optimize the clinical outcome and prolong the survival of patients with pancreatic cancer.

Keywords: autologous transplantation, intestines, abdominal cavity, pancreatic cancer, mesenteric tumors
p. 607-616 of the original issue
  1. Gote SV. Innovations in transplantology: heart transplantation program development in Russian Federation. Patologiia Krovoobrashcheniia i Kardiokhirurgiia. 2017;21(3s):61-68. (In Russ.)
  2. Tzakis AG, De Faria W, Angelis M, Verzaro R, Pinna A. Partial abdominal exenteration, ex vivo resection of a large mesenteric fibroma, and successful orthotopic intestinal autotransplantation. Surgery. 2000 Sep;128(3):486-9. doi: 10.1067/msy.2000.107165
  3. Wu G, Zhao Q, Wang W, Shi H, Wang M, Zhang J, Li Z, Fan D. Clinical and nutritional outcomes after intestinal autotransplantation. Surgery. 2016 Jun;159(6):1668-76. doi: 10.1016/j.surg.2016.01.016
  4. Kovaleva D, Dovzhanskii IV. Autotransplantatsiia kishki u detei. Forcipe. 2019;2 (spets vyp): 429-429. (In Russ.)
  5. Ivanov AP, Nabokov VV, Iakunin SI, Kopiakov AL, Kupatadze DD. Autotransplantatsiia kishki. Pediatr. 2017;8(s):179. Russ.)
  6. Hackert T, Schneider L, Büchler MW. Current state of vascular resections in pancreatic cancer surgery. Gastroenterol Res Pract. 2015;2015:120207. doi: 10.1155/2015/120207
  7. Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, Büchler MW. Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013 Jun;10(6):323-33. doi: 10.1038/nrclinonc.2013.66
  8. Gluth A, Werner J, Hartwig W. Surgical resection strategies for locally advanced pancreatic cancer. Langenbecks Arch Surg. 2015 Oct;400(7):757-65. doi: 10.1007/s00423-015-1318-7
  9. Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg. 2007 Mar;94(3):265-73. doi: 10.1002/bjs.5716
  10. Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011 Dec;254(6):882-93. doi: 10.1097/SLA.0b013e31823ac299
  11. Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB. Arterial resection at the time of pancreatectomy for cancer. Surgery. 2014 May;155(5):919-26. doi: 10.1016/j.surg.2014.01.003
  12. Amano H, Miura F, Toyota N, Wada K, Katoh K, Hayano K, Kadowaki S, Shibuya M, Maeno S, Eguchi T, Takada T, Asano T. In situ surgical procedures for locally advanced pancreatic cancer: partial abdominal evisceration and intestinal autotransplantation. J Hepatobiliary Pancreat Surg. 2009;16(6):771-76. doi: 10.1007/s00534-009-0188-1
  13. Nikeghbalian S, Aliakbarian M, Kazemi K, Shamsaeefar AR, Mehdi SH, Bahreini A, Malek-Hosseini SA. Ex-vivo resection and Small-Bowel Auto-transplantation for the treatment of tumors at the root of the mesentery. Int J Organ Transplant Med. 2014;5(3):120-24.
  14. Quintini C, Di Benedetto F, Diago T, Lauro A, Cautero N, De Ruvo N, Romano A, Di Sandro S, Ramacciato G, Pinna AD. Intestinal autotransplantation for adenocarcinoma of pancreas involving the mesenteric root: our experience and literature review. Pancreas. 2007 Mar;34(2):266-8. doi: 10.1097/MPA.0b013e31802edee9
  15. Tzakis AG, Pararas NB, Tekin A, González-Pinto IM, Levi D, Nishida S, et al. Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: long-term follow-up. Surgery. 2012 Jul;152(1):82-9. doi: 10.1016/j.surg.2012.01.003
  16. Kato T, Lobritto SJ, Tzakis A, Raveh Y, Sandoval PR, Martinez M, Granowetter L, Armas A, Brown RS Jr, Emond J. Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. Am J Transplant. 2012 May;12(5):1323-28. doi: 10.1111/j.1600-6143.2011.03945.x
  17. Kitchens WH, Elias N, Blaszkowsky LS, Cosimi AB, Hertl M. Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor. World J Surg Oncol. 2011;9:11. Published online 2011 Jan 31. doi: 10.1186/1477-7819-9-11
  18. Koskenvuo L, Peltomäki P, Renkonen-Sinisalo L, Gylling A, Nieminen TT, Ristimäki A, Lepistö A. Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis. J Surg Oncol. 2016 Feb;113(2):209-12. doi: 10.1002/jso.24117
  19. Ogawa N, Iseki H, Tsunozaki H, Hayashi M, Baba H, Matsuyama T, Uetake H, Sugihara K. Intra-abdominal desmoid tumor difficult to distinguish from a gastrointestinal stromal tumor: report of two cases. Surg Today. 2014 Nov;44(11):2174-79. doi: 10.1007/s00595-013-0681-7
  20. Mezhir JJ. The desmoid tumor: still an enigma. J Surg Res. 2012 Mar;173(1):46-8. doi: 10.1016/j.jss.2011.01.039
  21. Mullen JT, Delaney TF, Kobayashi WK, Szymonifka J, Yeap BY, Chen YL, Rosenberg AE, Harmon DC, Choy E, Yoon SS, Raskin KA, Petur Nielsen G, Hornicek FJ. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol. 2012 Dec;19(13):4028-35. doi: 10.1245/s10434-012-2638-2
  22. Neville A, Herts BR. CT characteristics of primary retroperitoneal neoplasms. Crit Rev Comput Tomogr. 2004;45(4):247-70.
  23. Osman S, Lehnert BE, Elojeimy S, Cruite I, Mannelli L, Bhargava P, Moshiri M. A comprehensive review of the retroperitoneal anatomy, neoplasms, and pattern of disease spread. Curr Probl Diagn Radiol. 2013 Sep-Oct;42(5):191-208. doi: 10.1067/j.cpradiol.2013.02.001
  24. Strauss DC, Hayes AJ, Thomas JM. Retroperitoneal tumours: review of management. Ann R Coll Surg Engl. 2011 May;93(4):275-80. doi: 10.1308/003588411X571944
  25. Wei J, Yang Y, Zheng J, Chen D, Wang W, Zhao Q, Li X, Wu G. Small intestinal autotransplantation for spontaneous isolated superior mesenteric artery dissection: A case report. Medicine (Baltimore). 2019 Nov;98(47):e17837. doi: 10.1097/MD.0000000000017837
  26. Kim YW. Current understandings of spontaneous isolated superior mesenteric artery dissection. Vasc Specialist Int. 2016 Jun; 32(2):37-43. Published online 2016 Jun 30. doi: 10.5758/vsi.2016.32.2.37
  27. Heo SH, Kim YW, Woo SY, Park YJ, Park KB, Kim DK. Treatment strategy based on the natural course for patients with spontaneous isolated superior mesenteric artery dissection. J Vasc Surg. 2017 Apr;65(4):1142-51. doi: 10.1016/j.jvs.2016.10.109
  28. Kochi K, Orihashi K, Murakami Y, Sueda T. Revascularization using arterial conduits for abdominal angina due to isolated and spontaneous dissection of the superior mesenteric artery. Ann Vasc Surg. 2005 May;19(3):418-20. doi: 10.1007/s10016-005-0018-0
  29. Li N, Lu QS, Zhou J, Bao JM, Zhao ZQ, Jing ZP. Endovascular stent placement for treatment of spontaneous isolated dissection of the superior mesenteric artery. Ann Vasc Surg. 2014 Feb;28(2):445-51. doi: 10.1016/j.avsg.2013.01.028
  30. Dubrova SE, Stashuk GA. Computed tomography in the diagnosis of acute mesenteric ischemia. Klin Gerontologiia. 2015;(7-8):16-20. Russ.)
  31. Lai DT, Chu KM, Thompson JF, Gallagher JP, Waugh R, Storey DW, Stephen MS. Islet cell carcinoma treated by induction regional chemotherapy and radical total pancreatectomy with liver revascularization and small bowel autotransplantation. Surgery. 1996 Jan;119(1):112-4. doi: 10.1016/s0039-6060(96)80223-6
  32. Zeng Y, Wu H, Yang JY. Small bowel autotransplantation combined with pancreato-duodenectomy for enormous cavernous hemangioma of the small intestine mesentery. Chin Med J (Engl). 2008 Oct 20;121(20):2110-12.
  33. Tzvetanov IG, Bhati CS, Jeon H, Glover AE, Oberholzer J, Benedetti E. Segmental intestinal autotransplantation after extensive enterectomy for removal of large intra-abdominal desmoid tumors of the mesentery root: initial experience. Surgery. 2012 Apr;151(4):621-24. doi: 10.1016/j.surg.2011.07.028
  34. Matsumoto S, Sekine K, Funaoka H, Yamazaki M, Shimizu M, Hayashida K, Kitano M. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. Br J Surg. 2014 Feb;101(3):232-38. doi: 10.1002/bjs.9331
  35. Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang H. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol. 2015 Oct;39(10):1395-403. doi: 10.1097/PAS.0000000000000491
Address for correspondence:
734003, Republic of Tajikistan,
Dushanbe, Rudaki Avenue, 139.
Avicenna Tajik State Medical University,
the Department of Surgical Diseases No1,
tel.: +992 928-21-77-55,
Ali-Zade Sukhrob G.
Information about the authors:
Mukhabbatov Dzhiyonkhon K., MD, Professor of the Department of General Surgery No1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan.
Gulov Makhmadshokh K., MD, Professor of the Department of General Surgery No1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan.
Ali-Zade Sukhrob G., PhD, Associate Professor of the Department of Surgical Diseases No1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan.
Nozimov Farkhod H., PhD, Assistant of the Department of General Surgery No1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan.



I.M. Sechenov First Moscow State Medical University, Moscow,
The Russian Federation

Nonparasitic splenic cysts (NPSCs) are uncommon lesions of the spleen, clinically, they may be asymptomatic. Their classification includes two basic groups: the true cysts or primary cysts and false or pseudo cysts based on the presence or absence of an epithelial lining. The need for surgery of nonparasitic cysts is due to the development of complications: suppuration, hemorrhage into the cavity of the cyst and its rupture. Historically, the conventional surgical method was splenectomy, however, complete removal of the organ, especially at a young age, often led to life-threatening infectious complications. Spleen-preserving surgery is considered to be an alternative to classical splenectomy: partial resection of the spleen and fenestration with excision of extra-hepatic cyst wall. However, as clinical practice has shown, these methods can be effectively used exclusively for the treatment of superficial cysts, and during the operation the ruptures of the capsule of the pathological focus with bleeding are observed. According to the general tendency in surgery to reduce the traumatization all patients were worked up with an ultrasound and X-Ray examination of the abdomen to look for the size and location of the splenic cysts. These operations include: drainage with sclerosing of the cyst and deepithelialization with superselective arterial embolization of the feeding vascular pedicle of the pathological focus. The study of these techniques revealed their weak points: the recurrence rate of cysts after sclerosis was 30-50%, and the use of embolizing agents in 50% of cases is complicated by ischemia of an organ segment with possible formation of an infarction zone in the early postoperative period. Nowadays the most promising method is considered to be a microwave ablation. Its thermal effect creates coagulation necrosis of the pathological focus and surrounding tissues with minimal toxic effects. This approach decidedly requires further research.

Keywords: splenic cyst, splenectomy, navigational surgery, percutaneous puncture, artery embolization, microwave ablation
p. 617-623 of the original issue
  1. Stepanova Yu.A., Alimurzaeva M.Z., Ionkin D.A. Ultrasonic differential diagnostics of cyst and cystic tumors of the spleen. Medical Visualization. 2020;24(3):63-75doi: 10.24835/1607-0763-2020-3-63-75. (In Russ.)
  2. Samarakoon LB, Si Min Goh S, Cheong YL, Ong LY. Massive splenic epidermoid cyst in a child treated with laparoscopic partial splenectomy case report and review of literature. Proc Singapore Healthc. 2019 Mar;28(1):61-64. doi: 10.1177/2010105818782523
  3. Chen YY, Shyr YM, Wang SE. Epidermoid cyst of the spleen. J Gastrointest Surg. 2013 Mar;17(3):555-61. doi: 10.1007/s11605-012-2088-y
  4. Andral G. Precis danatomie patliologique. Paris: Gabon; 1829. 432 p.
  5. Fowler RH. Nonparasitic benign cystic tumors of the spleen. Int Abstr Surg. 1953 Mar;96(3):209-27.
  6. Posta CG. Laparoscopic management of a splenic cyst. J Laparoendosc Surg. 1994 Oct;4(5):347-54. doi: 10.1089/lps.1994.4.347
  7. Hassoun J, Ortega G, Burkhalter LS, Josephs S, Qureshi FG. Management of nonparasitic splenic cysts in children. J Surg Res. 2018 Mar;223:142-48. doi: 10.1016/j.jss.2017.09.036
  8. Tuccari G, Giuffrè G, Muscarà M. Epidermoid cyst of the spleen: diagnosis suggested by fine-needle aspiration biopsy. Diagn Cytopathol. 1992;8(5):517-21. doi: 10.1002/dc.2840080512
  9. Shukla RM, Mukhopadhyay M, Mandal KC, Mukhopadhyay B. Giant congenital infected splenic cyst: An interesting case report and review of the literature. Indian J Surg. 2010 Jun;72(3):260-62. doi: 10.1007/s12262-010-0068-6
  10. Morgenstern L. Nonparasitic splenic cysts: pathogenesis, classification, and treatment. J Am Coll Surg. 2002 Mar;194(3):306-14. doi: 10.1016/s1072-7515(01)01178-4
  11. Schnorrer M, Fíger J, Labuda M. Splenectomy and sparing surgery of the spleen. Rozhl Chir. 1995 Mar;74(2):93-97. [Article in Slovak]
  12. Schlittler LA, Dallagasperina VW. Non-parasitic splenic cysts. Rev Col Bras Cir. 2010 Dec;37(6):442-46. doi: 10.1590/s0100-69912010000600011 [Article in English, Portuguese]
  13. Kubyshkin VA, Ionkin DA. Opukholi i kisty selezenki, Moscow, RF: ID Medpraktika-M; 2007. 288 p. (In Russ.)
  14. Kenney CD, Hoeger YE, Yetasook AK, Linn JG, Denham EW, Carbray J, Ujiki MB. Management of non-parasitic splenic cysts: does size really matter? J Gastrointest Surg. 2014 Sep;18(9):1658-63. doi: 10.1007/s11605-014-2545-x
  15. Pointer Jr DT, Slakey DP. Cysts and tumors of the spleen. In: Yeo CJ, Gross SD, Jefferson T, eds. Cover for Shackelfords Surgery of the Alimentary Tract. 2-Vol Set. Elsevier Inc; 2019. p. 1654-59. doi: 10.1016/C2015-1-00854-7
  16. Selby C, Hart S, Ispahani P, Toghill PJ. Bacteraemia in adults after splenectomy or splenic irradiation. Q J Med. 1987 Jun;63(3):523-30. doi: 10.1093/oxfordjournals.qjmed.a068122
  17. Pate JW, Peters TG, Andrews CR. Postsplenectomy complications. Am Surg. 1985 Aug;51(8):437-41.
  18. Maslyakov VV, Barsukov VG, Shumanov AYu, Shihmagomedov AZ. Physiological justification of organ-preserving operations spleen injuries. Kazan Med Zhurn. 2011;92(3):335-40. (In Russ.)
  19. Añon R, Guijarro J, Amoros C, Gil J, Bosca MM, Palmero J, Benages A. Congenital splenic cyst treated with percutaneous sclerosis using alcohol. Cardiovasc Intervent Radiol. 2006 Jul-Aug;29(4):691-93. doi: 10.1007/s00270-005-0144-7
  20. Poulin EC, Thibault C, DesCôteaux JG, Côté G. Partial laparoscopic splenectomy for trauma: technique and case report. Surg Laparosc Endosc. 1995 Aug;5(4):306-10.
  21. Manciu S, Tudor S, Vasilescu C. Splenic Cysts: A Strong indication for a minimally invasive partial splenectomy. could the splenic hilar vasculature type hold a defining role? world J Surg. 2018 Nov;42(11):3543-50. doi: 10.1007/s00268-018-4650-6
  22. Liu G, Fan Y. Feasibility and safety of laparoscopic partial splenectomy: a systematic review. World J Surg. 2019 Jun;43(6):1505-18. doi: 10.1007/s00268-019-04946-8
  23. Salky B, Zimmerman M, Bauer J, Gelernt I, Kreel I. Splenic cyst--definitive treatment by laparoscopy. Gastrointest Endosc. 1985 Jun;31(3):213-15. doi: 10.1016/s0016-5107(85)72049-4
  24. Milosavljević V, Tadić B, Grubor N, Erić D, Matić S. Laparoscopic technique as a method of choice in the treatment of non-parasitic splenic cysts. Srpski Arhiv za Celokupno Lekarstvo. 2019 Mar;147(5):307-10. doi: 10.2298/SARH181008029M
  25. Krasilnikov DM, Tolstikov AP. Surgical treatment of patients with non-parasitic hepatic cysts. Kreativ Khirurgiia i Onkologiia. 2012;25(5):481-87. doi: 10.24060/2076-3093-2012-0-1-91-97 (In Russ.)
  26. Karfis EA, Roustanis E, Tsimoyiannis EC. Surgical management of nonparasitic splenic cysts. JSLS. 2009 Apr-Jun;13(2):207-12.
  27. Kawamura J, Hiura M, Ueda M, Higashi Y, Yoshida O, Kuwahara C, Ueda M. Ultrasound-guided renal cyst puncture and 95% ethanol injection. Part 1: Estimation of ethanol levels in the blood and urine following 95% ethanol injection. Hinyokika Kiyo. 1984 Mar;30(3):287-94.
  28. Shiryaev AA, Musaev GH, Harnas SS, Ryabova AV, Kondrashin SA, Loshchenov VB, Volkova AI, Pominova DV, Akhmedova SM, Zhemerikin GA. Non-parasitic splenic cysts. Methods of surgical treatment. Vestn Khirurg Gastroenterologii. 2013;(4):26-32. (In Russ.)
  29. Akhan O, Dagoglu-Kartal MG, Ciftci T, Ozer C, Erbahceci A, Akinci D. Percutaneous treatment of non-parasitic splenic cysts: Long-term results for single- versus multiple-session treatment. Cardiovasc Intervent Radiol. 2017 Sep;40(9):1421-30. doi: 10.1007/s00270-017-1650-0
  30. Belyaeva AV, Polyaev AYu, Rosinov V. Nonparasitic splenic cysts in children (etiology, classification, organ preservation therapy) Ros Vestn Det Khirurgii, Anesteziologii i Reanimatologii. 2016;6(3):102-8. (In Russ.)
  31. Cairang Y, Zhang L, Ren B, Ren L, Hou L, Wang H, Zhou Y, Zhang Q, Shao J, Fan H. Efficacy and safety of ultrasound-guided percutaneous microwave ablation for the treatment of hepatic alveolar echinococcosis: A preliminary study. Medicine (Baltimore). 2017 Jul;96(27):e7137. doi: 10.1097/MD.0000000000007137
  32. Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics. 2014 Sep-Oct;34(5):1344-62. doi: 10.1148/rg.345140054
  33. Karpova R, Mishin A, Guseinov S. Microwave ablation of splenic cyst: A case report. Ann Med Surg (Lond). 2019 Apr 12;41:40-42. doi: 10.1016/j.amsu.2019.03.014. eCollection 2019 May.
  34. Luo N, Wang Y, Geng Z, Qin X. Analysis of feasibility, safety and effectiveness of ultrasound-guided percutaneous microwave ablation of splenic neoplasm. Oncol Lett. 2018 Oct;16(4):4807-12. doi: 10.3892/ol.2018.7845
Address for correspondence:
119435, Russian Federation,
Moscow, Bolshaya Pirogovskaya str., 6-1,
I.M. Sechenov First Moscow State Medical University,
the Department of Faculty Surgery No1,
tel. +7 916 478-37-65,
Chernousov Kirill F.
Information about the authors:
Karpova Radmila V., MD, Professor of the Department of Faculty Surgery No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Chernousov Kirill F., Post-Graduate Student, the Department of Faculty Surgery No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Russkova Ksenia S., a 6th-Year Student, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.




E.A. Vagner Perm State Medical University, Perm,
The Russian Federation

Cystic hamartoma refers to rare benign lung tumors. The literature describes 17 cases of this disease. The tumor may look like multiple bilateral cysts or a solitary single-chamber or multi-chamber cyst of a large size, which makes it difficult to diagnose. The disease can be complicated by spontaneous pneumothorax. The cyst itself often looks like a pneumothorax. An observation of a 52-year-old man complaining of chest pain and shortness of breath is presents. On the x-ray, the left lung is compressed with air, which is regarded as a spontaneous pneumothorax. Two-day drainage did not give any results. The video-assisted thoracoscopic surgery technique was performed and a large air cyst was detected. A conversion to a thoracotomy was made. A cyst of 20×15 cm size originated from the lower lobe, the lung was in atelectasis. Cyst resection and lung decortication were performed. Histological examination of the cyst wall revealed a hamartoma of the lung. The postoperative period was uneventful. Differential diagnosis of cystic hamartoma is conducting with lymphangioleiomyomatosis, air cysts, extrapulmonary sequestration, echinococcal cysts, and lung cancer. Indications for surgery are the following: chest pain, shortness of breath, pneumothorax, and hemoptysis. In a unilateral process, a cyst resection or lobectomy have to be performed. Cystic pulmonary hamartoma should be included in the differential diagnostic range in patients with recurrent spontaneous pneumothorax, hemoptysis, single and multiple lung cysts. It is impossible to determine the diagnosis without a biopsy and histological examination.

Keywords: cystic lung hamartoma, spontaneous pneumothorax, air lung cyst, benign lung tumors, videothoracoscopy
p. 624-628 of the original issue
  1. Shields TW, Locicero IIIJ, Reed CE, Feins RH, eds. General thoracic surgery. Wolters Kluwer/Lippincott Williams and Wilkins; 2009. 2616 p.
  2. Kuzdzal J, ed. ESTS Textbook of thoracic surgery. Cracow: medycyna praktyczna; 2014. 1084 p.
  3. Sellke FW, del Nido PJ, Swanson SJ, eds. 9th ed. Elsevier; 2016. 2586 p.
  4. Abu Omar M, Abu Ghanimeh M, Tylski E, Saettele T. Endobronchial hamartoma: a rare disease with more common presentation. BMJ Case Rep. 2016 Nov 7;2016:bcr2016216771. doi: 10.1136/bcr-2016-216771
  5. Fasanya AA, Hattab Y, Patel A, Lega M. Mesenchymal cystic hamartoma of the lung. Respir Med Case Rep. 2017 May 12;21:158-60. doi: 10.1016/j.rmcr.2017.05.004. eCollection 2017.
  6. van Klaveren RJ, Hassing HH, Wiersma-van Tilburg JM, Lacquet LK, Cox AL. Mesenchymal cystic hamartoma of the lung: a rare cause of relapsing pneumothorax. Thorax. 1994 Nov;49(11):1175-76. doi: 10.1136/thx.49.11.1175
  7. Chadwick SL, Corrin B, Hansell DM, Geddes DM. Fatal haemorrhage from mesenchymal cystic hamartoma of the lung. Eur Respir J. 1995 Dec;8(12):2182-84. doi: 10.1183/09031936.95.08122182
  8. Saadi MM, Barakeh DH, Husain S, Hajjar WM. Large multicystic pulmonary chondroid hamartoma in a child presenting as pneumothorax. Saudi Med J. 2015 Apr;36(4):487-89. doi: 10.15537/smj.2015.4.10210
  9. Chida M, Minowa M, Eba S, Odajima H. Mesenchymal cystic hamartoma of the lung: a rare cause of pneumothorax. Gen Thorac Cardiovasc Surg. 2009 Mar;57(3):166-68. doi: 10.1007/s11748-008-0333-9
  10. Ozbudak IH, Dertsiz L, Bassorgun CI, Ozbilim G. Giant cystic chondroid hamartoma of the lung. J Pediatr Surg. 2008 Oct;43(10):1909-11. doi: 10.1016/j.jpedsurg.2008.06.007
  11. Yorita K, Ayabe T, Chosa E, Uchino N, Nagatomo Y, Yamaguchi T, Nakatani Y, Kataoka H. Unusual cystic hamartomatous lung lesion with clinical manifestation of subpleural bullae in a woman of reproductive age: A case report. Pathol Int. 2015 Oct;65(10):558-62. doi: 10.1111/pin.12342
  12. Kim GY, Han J, Kim DH, Kim J, Lee KS. Giant cystic chondroid hamartoma. J Korean Med Sci. 2005 Jun;20(3):509-11. doi: 10.3346/jkms.2005.20.3.509
  13. Argemi X, Santelmo N, Matau C, Croce S, Weingertner N. Cystic lung lesions mimicking hydatidosis: hamartoma or benign metastazing leiomyoma? Ann Thorac Surg. 2019 Sep;108(3):e195-e198. doi: 10.1016/j.athoracsur.2019.01.044
  14. Greenspon A, Samuels L, Greenspon L. Extralobar sequestration complicated by a cystic hamartoma in an adult. Ann Thorac Surg. 2019;108(1):e43-e44. doi: 10.1016/j.athoracsurg.2018.10.072
  15. Glezos J, Toppin D, Cooney T. Mesenchymal cystic hamartoma presenting with spontaneous pneumothorax. Can Respir J. 2003 Jul-Aug;10(5):280-81. doi: 10.1155/2003/595082
Address for correspondence:
614990, Russian Federation,
Perm, Petropavlovskaya Str., 26,
E.A. Vagner Perm State Medical University,
the Surgery Department with the Course
of Cardiovascular Surgery
and Interventional Cardiology
tel. +7 342 239-29-72,
Plaksin Sergei A.
Information about the authors:
Plaksin Sergei A., MD, Professor of the Surgery Department with the Course of Cardiovascular Surgery and Interventional Cardiology
E.A.Vagner Perm State Medical University, Perm, Russian Federation.



A.N. Bakoulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation, Moscow,
The Russian Federation

The paper presents a description of a case of successful one and a half ventricular correction of a complex congenital cardiac anomalies, including the common atrioventricular canal, tetralogy of Fallot, and hypoplasia of the right ventricle in a child (2 year and 4 months). A rare congenital anomaly characterized by a combination of intracardiac defects, required an innovative surgical approach, the exclusivity of this clinical case has determined.
The surgical strategy of complete atrioventricular canal defect is determined by a number of factors. One of the most important is balance between right and left ventricular outputs. The balanced type with adequate development of the ventricles involves the biventricular repair performance. Unbalanced atrioventricular canal defects include a hypoplastic ventricle. Reconstructive surgery for one hypoplastic ventricle is oriented towards the degree of hypoplasia. In particular, a mild right ventricular hypoplasia allows perfoming biventricular radical operation while a severe degree suggests univentricular repair. In case of borderline, moderate degree of hypoplastic right ventricle the one and half ventricle repair can be carried out. Another important point is the presence of concomitant pulmonic stenosis required the choice of optimal method and material for reconstruction which is not always obvious and often it is the subject of debates. This report presents a description of the diagnostic stages with an emphasis on determining the type of balance of the common atrioventricular canal, the degree of hypoplasia of the right ventricle, the approach to choosing the optimal method for correcting the defect in general and the material for reconstructing the outflow pathway from the right ventricle in particular, as well as the subsequent successful correction of congenital multicomponent cardiac abnormalities in a young patient.

Keywords: young children, complete atrioventricular canal defect, tetralogy of Fallot, one and half ventricle repair, pulmonary allograft
p. 629-635 of the original issue
  1. Kanani M, Elliott MF. Atrioventricular Septal Defects. In: Yuh DD, Vricella LA, Yang SC, Doty JR (eds.) Johns Hopkins Textbook of Cardiothoracic Surgery. 2-nd ed. McGraw-Hill Education; 2014. . 1043-61.
  2. Gorbachevskii SV. Obshchii atrioventrikuliarnyi kanal. V kn: Bokeriia LA, Shatalov KV. (red.) Detskaia kardiokhirurgiia: ruk dlia vrachei. FGBU im. AN Bakuleva MZ RF; 2016. r. 344-61.(In Russ.)
  3. Kouchoukos NT, Blackstone EH, Hanley FL, Kirklin JK. Kirklin/Barratt-Boyes cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 4-th ed. Philadelphia: Elsevier; 2013. 2054 p.
  4. Meza JM, Devlin PJ, Overman DM, Gremmels D, Baffa G, Cohen MS, Quartermain MD, Caldarone CA, Pourmoghadam K, DeCampli WM, Fackoury CT, Mertens L. The Congenital Heart Surgeons Society Complete Atrioventricular Septal Defect Cohort: Baseline, Preintervention Echocardiographic Characteristics. Semin Thorac Cardiovasc Surg. 2019 Spring;31(1):80-86. doi: 10.1053/j.semtcvs.2018.02.004
  5. Chowdhury UK, Airan B, Talwar S, Kothari SS, Saxena A, Singh R, Subramaniam GK, Juneja R, Pradeep KK, Sathia S, Venugopal P. One and one-half ventricle repair: results and concerns. Ann Thorac Surg. 2005 Dec;80(6):2293-300. doi: 10.1016/j.athoracsur.2005.05.052
  6. Podzolkov VP, Zelenikin MA, Samsonov VB, Makhachev OA, Chiaureli MR, Putyato NA, Chernogrivov IE. One and a half ventricular correction in the surgical treatment of congenital heart failure. Vestn RAN. 2009;(1):25-30. ttps:// item.asp?id=12775648.(In Russ.)
  7. Talwar S, Siddharth B, Choudhary SK, Airan B. One and half ventricle repair: rationale, indications, and results. Indian J Thorac Cardiovasc Surg. 2018 Jul;34(3):370-80. doi: 10.1007/s12055-017-0628-5
  8. Forbess JM. Conduit selection for right ventricular outflow tract reconstruction: contemporary options and outcomes. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;(7):115-24. doi: 10.1053/j.pcsu.2004.02.004
  9. Boethig D, Horke A, Hazekamp M, Meyns B, Rega F, Van Puyvelde J, Hübler M, Schmiady M, Ciubotaru A, Stellin G, Padalino M, Tsang V, Jashari R, Bobylev D, Tudorache I, Cebotari S, Haverich A, Sarikouch S. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data. Eur J Cardiothorac Surg. 2019 Sep 1;56(3):503-509. doi: 10.1093/ejcts/ezz054
  10. Malhotra A, Agrawal V, Patel K, Shah M, Sharma K, Sharma P, Siddiqui S, Oswal N, Pandya H. Ebsteins Anomaly: The One and a Half Ventricle Heart. Braz J Cardiovasc Surg. 2018 Jul-Aug;33(4):353-61. doi: 10.21470/1678-9741-2018-0100
Address for correspondence:
121552, The Russian Federation,
Moscow, Rublevskoe Highway, 135,
A.N. Bakoulev National Medical
Research Center for Cardiovascular Surgery,
Surgery Department of Young Children
With Congenital Heart Diseases,
Tel. mobile: +79260310316,
Dmitry K. Guschin
Information about the authors:
Guschin Dmitriy K., Researcher, Cardiovascular Surgeon of the Department of Congenital Heart Diseases Surgery in Young Children, .N. Bakoulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation, Moscow, the Russian Federation.
Volkov Sergey S., PhD, Senior Researcher, Cardiovascular Surgeon of the Department of Congenital Heart Diseases Surgery in Young Children, .N. Bakoulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation, Moscow, the Russian Federation.
Shcherbak Anastasia V., Cardiovascular Surgeon of the Department of Congenital Heart Diseases Surgery in Young Children, .N. Bakoulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation, Moscow, the Russian Federation.
Zelenikin Mikhail M., MD, Professor, Chief of the Department of Congenital Heart Diseases Surgery in Young Children,.N. Bakoulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation, Moscow, the Russian Federation.
Contacts | ©Vitebsk State Medical University, 2007-2023